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Abstract
Bach, Michael T., M.A. October, 2000 Psychology
The Relationship o f Health Beliefs, Knowledge o f Disease, and Social Support to Health- 
Related Quality of Life in Patients with Inflammatory Bowel Disease
Director: D Balfour Jeffrey, Ph.D.
A great deal o f research has been done to develop treatments that alleviate the physical 
symptoms of inflammatory bowel disease (IBD) In addition, the effects of 
pharmaceutical and surgical interventions on a patient’s health-related quality o f life 
(HRQOL) are currently acknowledged as important considerations. Despite this 
research, however, and despite interest in the psychological factors that may play an 
etiological role in IBD, little research has been done to determine the situational and 
personality variables that contribute to HRQOL in IBD.
The primary hypothesis of this study was that a person’s disease activity, health beliefs, 
knowledge about IBD, and satisfaction with social support will account for more o f the 
variance in HRQOL scores than will disease activity alone. To test this hypothesis, 
subjects with IBD were recruited from doctors’ offices, an on-line chat group, and an 
IBD newsletter, and they completed several questionnaires that measured the above 
constructs. Stepwise multiple regression and correlational methods revealed that, 
although disease activity was a significant predictor o f all aspects o f HRQOL, of the 
remaining variables, only satisfaction with social support provided additional predictive 
ability. Post-hoc analyses suggest that social support may be a better predictor of 
HRQOL in ulcerative colitis patients than in those with Crohn’s disease. Analyses o f the 
HRQOL measurement (the IBDQ) suggest that it is a valid and reliable instrument, but 
that the four subscales are too highly correlated to be treated as measuring separate 
components o f HRQOL.
Future research should continue to refine the IBDQ and to clarify the conceptual 
definition o f HRQOL. In addition, the question of whether ulcerative colitis and Crohn’s 
disease patients differ with respect to the role o f social support should be addressed, in 
order to help both groups of patients experience the highest possible degree of HRQOL.
11
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table of Contents
Abstract ii
List of Tables . . . . . . .  vi
Acknowledgements . . . . . . .  vii
Chapter
1. Introduction
Overview . . . . . . . .  1
A Description o f EBD . . . . . . .  2
A Clarification of This Study’s Purpose . . . . 4
Research Concerning the Pharmaceutical Treatment o f IBD 6
A Popular Measure of Disease Activity—the CD AI 7
Other Disease Activity Measures 11
The Chapel Hill Index . . . . . .  12
Objective vs. Subjective Measures o f Disease Activity. 14
Quality o f Life and HRQOL: Background and Definitions . 16
Criticisms o f Generic and Global HRQOL Instruments 19
The EBDQ: A Disease-Specific HRQOL Instrument 20
Other Health-Related Quality o f Life Scales . . . 27
Research Concerning HRQOL in EBD Patients 31
The Use of HRQOL Instruments as Outcome Measures in Clinical Trials 32 
The Relationship Between Disease Activity and HRQOL 34
Theory About Factors that Influence HRQOL in IBD Patients 36
The Relationship o f Health Locus of Control to HRQOL in Other Groups 37
111
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
The Relationship of Health Locus of Control to HRQOL in IBD Patients 38 
Measurement o f Health Locus o f Control . . . .  42
The Relationship o f Patient Knowledge to HRQOL in Other Groups 46
The Relationship of Patient Knowledge to HRQOL in IBD Patients. 47
Measurement o f Patient Knowledge . . . . .  48
The Relationship o f Social Support to HRQOL in Other Groups 50
The Relationship o f Social Support to HRQOL in IBD Patients 50
Measurement of Social Support . . . . .  53
Purpose and Hypotheses 55
2. Method . . . . . . . . .  57
Participants . . . . . . . .  57
Materials . . . . . . . .  57
Procedure . . . . . . . .  59
3. Results . . . . . . . . .  61
4. Discussion. . . . . . . . .  72
References. . . . . . . . . .  82
Appendices
A. Demographic Questionnaire . 91
B. Inflammatory Bowel Disease Questionnaire . . . .  92
C. Chapel Hill Index . . . . . .  95
D Multidimensional Health Locus o f Control Scale . . .  96
E. Knowledge Questionnaire . . . . . .  97
F. Social Support Questionnaire (SSQ-6) . . . .  99
IV
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
G. Institutional Review Board Proposal.. 102
H. Participant Instructions 106
I IBDQ Items According to Subscale . 107
J. Means and Standard Deviations for Scales in the Crohn’s Disease and
Ulcerative Colitis Groups 109
K. Announcement o f Study in IBD Newsletter . 110
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
List of Tables
1. Demographic Features of 62 IBD Patients . . . . 62
2. Mean, Standard Deviation, Range, and Total Possible o f the Scales. 63
3. Regression Analyses for IBDQ Subscales and Total Score . 65
4. Scale Intercorrelations of the IBDQ . . . . .  66
5. Probabilities and Partial Correlation Coefficients of Excluded Variables
in the Five Regression Equations . . . . .  68
6. Interaction Between Disease Activity and Social Support 69
7. Regression Analyses for Crohn’s Disease vs. Ulcerative Colitis 70
8. Probabilities and Partial Correlation Coefficients for Excluded Variables
in Ulcerative Colitis Patients . 71
VI
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Acknowledgements
No work would be complete without a word o f thanks to those people who have 
made it possible. I could never see such a large project through to completion on my 
own, thus it is only fitting to include such a thanks at its beginning. I would like to thank:
Bal Jeffrey, my thesis advisor, who has made innumerable and valuable 
suggestions to me and who has consistently shown a keen ability to solve would-be 
problems.
My committee members, John Klocek, David Schuldberg, and Sharon Uhlig, for 
the excellent suggestions made at my prospectus meeting and for allowing me some 
flexibility with the sample size.
Dr. Noren, for without your willingness to participate, I would never have begun 
the study.
Dr. Morris, Dr. Mumey, and Dr. Travis for allowing me to place questionnaires in 
your offices.
All the nurses who did the actual distributing o f questionnaires.
Cathy Michalec o f the Crohn’s and Colitis Foundation o f America, who 
enthusiastically suggested a posting of the study in the Foundation’s newsletter and 
distribution of questionnaires to support groups.
John Caruso, for taking the time to consult with me regarding several statistical 
analyses.
Tom and Barb Bach, who encouraged me to excel not only academically, but in 
all areas of my life through their instruction and example.
My wife Jen, who has encouraged me to continue despite the tremendous sacrifice 
o f time and energy. If  I didn’t feel your support, I wouldn’t have finished
Alaina. You haven’t been alive as long as this project has been underway, but 
you have shown much interest in the printing of rough drafts.
Lastly, but certainly not in the least, the LORD, for giving me the peace of mind 
necessary to accomplish tasks in this life, and a sure hope for the life to come.
V II
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
The Relationship o f Health Beliefs, Knowledge o f Disease, and Social Support to 
Health-Related Quality o f Life in Patients with Inflammatory Bowel Disease
Chapter 1 
Introduction
Overview
This study will attempt to clarify how several different factors are related to 
health-related quality o f life in patients with inflammatory bowel disease, or IBD First 
this disease will be described, and research concerning its pharmaceutical treatment will 
be discussed- It will then be argued that symptom description alone, as measured by 
current disease activity indices, does not fully capture the patient’s experience; health- 
related quality of life is also important.
After discussing the definitions o f quality o f life and health-related quality of life 
(HRQOL), literature describing what is known about HRQOL in EBD patients will be 
presented. Because current research indicates that disease activity alone does not fully 
account for variance in HRQOL scores, the relationship between disease severity and 
HRQOL will also be addressed. Based on a literature review, the following additional 
factors HRQOL appear worth investigating: health locus o f control; patient knowledge 
o f disease; and satisfaction with social support.
To answer the question “How do the above factors relate to health-related quality 
o f life in EBD patients?” questionnaires were filled out by subjects seeing 
gastroenterologists in Marquette, MI and Missoula, MT. Additional subjects were also 
recruited by posting a study announcement on an Internet message board and in an EBD 
newsletter. All patients filled out the questionnaires at home, then mailed them to the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
experimenter in Montana. The relationship between the above variables and HRQOL 
was determined by calculating several multiple regression equations and correlation 
coefficients. In addition, the internal consistency and intercorrelation of the subscales of 
the HRQOL instrument were computed.
A Description o f  IBD
Inflammatory bowel disease affects about 400,000 people in the United States 
(Mendeloff, 1980) and millions o f people worldwide. Consisting of two different 
illnesses, Crohn’s disease and ulcerative colitis, IBD is a lifelong condition characterized 
by periods o f activity and remission that continue throughout a person’s life. Although 
its genetic and environmental precursors have been studied, the etiology o f IBD is 
presently unknown (Reif, Klein, Lubin, Farbstein, Hallak, & Gilat, 1997). Men and 
women are affected roughly equally by IBD, and it is usually diagnosed before they are 
30 (Mendeloff, 1980). Although Crohn’s disease and ulcerative colitis share some of the 
same symptoms, such as diarrhea and abdominal pain, the two present themselves 
differently to both patients and clinicians.
Crohn’s disease can inflame any part of the alimentary tract, from the mouth to 
the anus, although this inflammation occurs primarily in the small and large intestines 
(Whitehead, 1980). During an exacerbation, its sufferers can experience severe 
abdominal pain, weight loss, fatigue, and diarrhea (Myren, Bouchier, Watkinson, Softley, 
Clamp, & deDombal, 1984), as well as joint pain and complications in the perianal area 
(Kombluth, Salomon, & Sachar, 1993). Examination often reveals scar tissue, which 
may narrow the intestines in different areas. The inflammation caused by Crohn’s
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
disease is typically deeper than the first layer, or mucosa, of the intestines, and can lead 
to fistulae, abnormal passages between internal organs (Kombluth, Salomon, & Sachar, 
1993). There is currently no cure for Crohn’s disease and, although surgery can be used 
to remove inflamed sections of intestine, the condition usually returns, bringing 
continued symptoms (Farmer, Easley, & Farmer, 1992).
The inflammation involved in ulcerative colitis, by contrast, is limited to the large 
intestine, and typically involves the rectum (Morson, 1980). The disease is marked by 
frequent and bloody diarrhea, which may lead to anemia (Myren et al., 1984, Jewell, 
1993). Other symptoms during an exacerbation include abdominal pain, fever, nausea, 
weight loss, joint pain and eye irritation (Jewell, 1993). The damage done to the large 
intestine is usually limited to the mucosa (Morson, 1980). Currently, the only cure for 
the disease is removal of the colon (Morson, 1980), which occurs in about 30% of 
patients.
Despite the differences in the severity and location o f inflammation in Crohn’s 
disease and ulcerative colitis, the two have many similarities and are categorized under 
the common heading o f IBD. As mentioned above, both diseases are caused by unknown 
factors, and have a clinical course o f exacerbation and remission. Although they are 
reliably distinguished from each other today (Myren et al., 1984), the similar symptoms 
made the two easily confused by physicians until about 40 years ago, when examination 
o f the colon became more common (Taylor, 1980).
The exact medication used depends on the severity of the disease and the response 
o f the individual, however, both diseases are treated with similar drugs (Jewell, 1993; 
Kombluth, Salomon, & Sachar, 1993). Although symptoms can be severe during relapse.
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most patients experience periods of remission during which they are able to perform daily 
activities without significant interference (Drossman, Lesserman, Mitchell, Zhiming, 
Zagimi, & Patrick, 1991; Joachim & Milne, 1987). Because of these similarities, the two 
diseases are frequently grouped together in studies (Farmer, Easley, & Farmer, 1992; 
Irvine et al., 1994; Martin, Leone, & Naccarato, 1995), and they will also be grouped 
together in this study.
A Clarification o f  the Purpose o f  This Study
Before examining the outcome research of drug therapy for IBD, it is necessary to 
clarify the focus of the present study. Although psychological factors and their 
relationship to disease activity are of interest, no assumption is made that these factors 
contribute to the development or severity o f the disease. Many studies have posited a 
link between personality and IBD, going as far as stating that EBD (especially ulcerative 
colitis) is caused by certain psychological liabilities.
Aronowitz and Spiro (1988) traced the development o f this interest to a paper by 
Murray that appeared in 1930. In this paper, Murray noted that patients with ulcerative 
colitis were characterized by a personality style that included fearfiilness, conflict and 
dependence. This idea was further refined in 1950 when Franz Alexander, a 
psychoanalyst, proposed the specificity hypothesis; certain psychological conflicts (such 
as the desire to be independent and the desire to be cared for) lead to specific patterns of 
arousal in the autonomic nervous system. This arousal then causes damage to particular 
areas of tissue (the colon in the case o f  ulcerative colitis). Many psychodynamic studies 
followed, with the general agreement that some event (perhaps a narcissistic wound)
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preceded the exacerbation or occurrence of symptoms, which served as a substitute for 
direct aggression or action (Chessick, 1995). Although researchers have searched for a 
personality style common to those with Crohn’s disease, this illness has received less 
attention than ulcerative colitis. This is most likely due to the fact that Crohn’s disease 
was described at a later time than was ulcerative colitis (North and Alpers, 1994).
Although researchers developed complex psychosomatic theories explaining the 
etiology o f IBD (particularly ulcerative colitis), their study methodologies have been 
criticized on many grounds, for example, sampling bias, lack of control groups, 
unsystematic collection of data in a retrospective manner, and the use of cross-sectional 
rather than longitudinal designs (North and Alpers, 1994; Zuckerman and Briones, 1989). 
Two recent reviews concluded that there is no “IBD personality” and that patients with 
ulcerative colitis do not have a higher than normal rate o f psychiatric diagnosis (North 
and Alpers, 1994; Zuckerman and Briones, 1989). Although some studies have found 
that Crohn’s patients have more diagnoses o f anxiety and depression than patients with 
ulcerative colitis (North and Alpers, 1994; Sheffield and Carney, 1976), it is not clear 
whether these symptoms precede the disease or if  they are a reaction to it (Addolarato, 
Stefanini, Capristo, Caputo, Gasbarrini, and Gasbarrini, 1996). In summary, whether or 
not the onset or course of IBD is influenced by stress or other emotional factors is unclear 
at this time. Although these unanswered questions remain, the purpose o f this study is 
not to investigate the mental or emotional liabilities o f people with IBD, but rather to 
examine the psychological strengths that may assist them in adapting to the illness.
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Research Concerning the Pharmacological Treatment o f  IBD
Although patients with both diseases may require surgery, their symptoms are 
usually managed with some type of pharmaceutical therapy (Jewell, 1993; Kombluth, 
Salomon, & Sachar, 1993). In a two-year study involving over 400 patients with Crohn’s 
disease (Malchow, Ewe, Brandes, Goebell, Ehlms, Sommer, & Jedinsky, 1984), patients 
were randomly assigned to six-week treatments of either 6-methylprednisolone alone, 6- 
methylprednisolone combined with sulfasalazine, sulfasalazine alone, or a placebo. 
Disease activity was measured with Crohn’s Disease Activity Index (CDAI; Best, 
Becktel, Singleton, & Kern, 1976) and the van Hees index (van Hees, van Elteren, van 
Lier, & van Tongeren, 1980), which will be discussed below. The disease activity of 
patients who responded to treatment was measured for up to two years. Analysis o f the 
treatments revealed that, overall, 6-methylprednisolone was the most effective regimen.
It was also superior at reducing disease activity in previously treated patients and in 
subgroups with inflammation in the small intestine only, or in both the small and large 
intestines. The combination therapy was most effective for previously untreated patients, 
and for those with inflammation in the large intestine only.
Powell-Tuck, Bown, & Lennard-Jones (1978) investigated two types of 
corticosteroid treatment for patients with ulcerative colitis. Corticosteroids had been 
shown efficacious in this population (Truelove & Witts, 1955), but a comparison of 
single vs. divided dosages had not been made Powell-Tuck et al. randomly assigned 45 
patients to one o f two groups. Twenty-three patients received a treatment of 40 mg. of 
prednisolone in the morning, and 22 received the same total amount in four separate 
administrations each day. The authors reported no differences among the treatments in
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terms o f disease activity, speed of response, or side effects, and recommended that 
patients be given the more convenient single dosage.
Many other studies have been done to test different drug treatments for IBD (for 
example, Archambault, Feagan, Fedorak, Groll, Irvine, Kinnear, Laupacis, McDonald, 
Rochon, Saibil, 1991; Truelove & Witt, 1955; Yacyshyn, Bowen-Yacyshyn, Jewell, 
Tami, Bennett, Kisner, & Shanahan, 1998). They have typically involved great 
methodological rigor, using valid and reliable outcome measures o f disease activity and 
placebo control groups. Subjects have been randomly assigned to groups, and both they 
and the medical staff were blind to treatment condition. Despite the care put into these 
studies, however, criticisms have increased recently regarding the outcome measures 
used—measures that ignore HRQOL (Garrett & Drossman, 1990; Martin, Leone, Fries, 
& Naccarato, 1995; Talal & Drossman, 1995). These criticisms will be discussed later, 
but first several disease activity scales will be described.
A Popular Measure o f  Disease Activity— The CDAI
Many researchers have attempted to quantify disease activity so that different 
drug treatments of IBD can be evaluated. The earliest measure of disease activity in 
Crohn’s disease was the Crohn’s Disease Activity Index (CDAI; Best et al., 1976). The 
CDAI contains a patient-completed questionnaire that asks about symptoms such as 
abdominal pain, feelings o f well-being, and the number o f loose stools per week. The 
patient fills out this questionnaire over a one-week period. The physician then adds 
information and a score is calculated. The CDAI was designed to be convenient, 
sensitive to change, and to correlate with physician assessments o f disease activity.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Scores o f less than 150 are defined as inactive disease, while scores above 450 indicate 
very severe activity.
Gastroenterologists from 13 universities and medical centers designed the CDAI. 
Through discussion, they chose 18 factors they thought were important for assessing 
disease activity. This list was later reduced to eight, which will be described below.
Data was gathered from 112 outpatients who had previously been diagnosed with 
Crohn’s disease and who recorded data on a one-week diary card that was turned in at 
each visit (total of 187 visits). About 75% of the subjects were receiving medical 
treatment for their Crohn’s disease.
A multiple regression equation was used to predict the physician assessment. The 
categories o f physician assessment o f the patient’s health and the number assigned to 
them were: (1) very well; (3) fair to good; (5) poor; or (7) very poor. When patients 
returned for a follow-up visit, the physicians also gave a rating o f the patient’s change 
since the last visit. These ratings were: much better; slightly better; the same; slightly 
worse; or much worse. In addition to these physician ratings, the patient diary cards 
containing information about abdominal pain, feelings o f well-being, and the number of 
loose stools per week were collected at each visit.
Once all the data were collected, the number of independent variables was 
reduced from 18 to 12 using multiple regression with stepwise deletion. Further deletion 
reduced this number to eight. These are, in the order they appear on the final CDAI: 
number o f liquid or very soft stools per week; sum of seven daily abdominal pain ratings; 
sum of seven daily ratings o f general well-being; the presence o f various extraintestinal 
symptoms (e.g., arthralgia, mouth lesions, skin rash, etc); whether or not the person was
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
taking opiates for diarrhea; the presence or absence o f an abdominal mass; hematocrit 
value; and bodyweight.
The authors displayed a figure showing the relationship between the computed 
CDAI score and the physician rating o f disease. Although no statistics regarding the 
agreement between the two ratings were reported, the authors note that, “increasingly 
unfavorable subjective physician’s ratings are associated with tendencies toward 
increasingly higher CDAI values, but moderate overlap o f ranges occurs” (p. 442). A 
later publication stated that the correlation between the CDAI score and the physician 
assessment was .70 (Sandler, Jordan, & Kupper, 1988).
Test-retest data was not reported for the CDAI. Instead, the authors reported 
retest data from 13 patients with 18 visits whose therapy was unchanged during the data 
collection period. Most o f the physician ratings o f change were “the same.” The 
reported pooled standard deviation o f the repeated administration was 45.5 CDAI units. 
The authors did not discuss whether they thought this finding provided evidence o f the 
CDAI’s reliability. Another study, however, reported a test-retest correlation (eight week 
period) o f .66 (Irvine et al., 1994). It should be noted, however, that the disease activity 
in Crohn’s disease can change substantially in eight weeks, which may explain the 
moderate correlation.
deDombal and Softley ( 1987) also examined the CDAI, and they reported 
considerable observer variation in the scores o f various disease activity indices, including 
the CDAI They had seven physicians who used the CDAI in daily practice assign CDAI 
scores to 10 construed case histories. A figure showing the distribution of CDAI scores 
for each case was referred to and, although no statistical procedures were described, the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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authors noted “considerable discrepancy” (p. 476). They also observed that much o f this 
discrepancy seemed attributable to one or two of the observers who may have been less 
familiar with the CDAI. A table revealed a smaller range of scores when the more 
extreme high and low values were eliminated. Examples o f the means and ranges were; 
132, with a range of 108-162; 261, with a range o f 235-310; 305, with a range o f 280- 
330; and 391, with a range o f 373-472. Again, no statistics were used to describe the 
table.
The items that caused the most disagreement concerned what defined a liquid 
stool, what factors were considered extraintestinal, the hematocrit value, and the 
calculation o f ideal body weight. The authors noted that small discrepancies were 
multiplied in the calculation of the final CDAI score. They recommended that the 
variables in the CDAI be clarified in order to increase inter-observer reliability.
Finally, Goebell, Wienbeck, Schomerus, & Malchow (1990) analyzed data 
concerning the CDAI that were gathered from a large study (described above) of Crohn’s 
disease patients (Malchow et al., 1984). In addition to completing the CDAI, three 
gastroenterologists who were blind to the CDAI score gave each patient a disease rating 
of 1 (not active), 2 (slight), 3 (moderate), 4 (severe), or 5 (very severe). An inter-rater 
reliability coefficient was not reported, but the authors stated that in 78% of the cases all 
three physicians gave the same score. A single clinical rating was then calculated from 
these ratings. The correlation between the CDAI and the clinical rating in this study was 
.88. It should be noted, however, that because o f its subjective nature, the general well­
being category o f the CDAI was omitted.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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In conclusion, these results and those o f the above studies suggest that, although 
the CDAI has limitations (such as moderate reliability), it is probably as trustworthy as 
the rating by a medical expert; that is, it taps into domains that gastroenterologists 
consider important when making judgements about their patients’ disease activity. The 
difficulty o f finding a “gold standard” for the validation o f disease activity measures, 
which is discussed below, has likely contributed to the popularity o f  the CDAI in 
research (Malchow et al, 1984; Yacyshyn et al, 1998).
Other Disease Activity Measures
Disease activity scales have also been designed for use with ulcerative colitis 
patients. Truelove and W itt’s (1955) scale for ulcerative colitis uses objective factors 
such as body temperature, resting heart rate and hemoglobin count. Although widely 
used, this instrument is not sensitive to small degrees of change in activity because of its 
categorical classification scale— mild, moderate or severe (Singleton, 1987). In attempts 
to improve Truelove and Witt’s scale, a number of new indices for ulcerative colitis have 
been created. These include the St. Mark’s index (Powell-Tuck, Bown, & Lennard- 
Jones, 1978), an instrument designed by Seo, Okada, Yao, Ueki, Arima, & Okumura 
(1992), and another measure that is a modification o f Truelove and Witt’s scale (Gomes, 
duBoulay, Smith, & Holdstock, 1986). These scales produce numerical severity scores 
based on a number o f objective and subjective factors.
Some researchers have criticized the CDAI as unreliable and lacking objectivity 
because o f the influence o f subjective— patient-reported—factors on its score (Crama- 
Bohbouth, Pena, Biemond, Verspaget, Blok, Arndt, Weterman, Pauwels, & Lamers,
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1989; van Hees, et al., 1980). Efforts to make improvements over the CDAI have 
generally consisted of either simplifying it, or including objective parameters. Harvey 
and Bradshaw’s (1980) scale is simpler to administer than the CDAI, but correlates 
highly with it. The Dutch (van Hees et al., 1980) and Cape Town indices (Wright,
Marks, & Parfitt, 1985) were created to assess the more objective aspects of the illness.
The Chapel Hill Index
The Chapel Hill Index (CHI; Sandler et al., 1988) was designed to produce scores 
comparable to the CDAI without the need for a physical exam or laboratory work. It was 
originally designed for survey research with Crohn’s patients, but has also been used to 
assess disease activity in subjects with ulcerative colitis. Because it will be used in this 
study, it is described in detail below.
The CHI was designed based on data from a trial o f sulfasalazine as a treatment 
for Crohn’s disease (Singleton, Summers, Kern, Becktel, Best, Hansen, & Winship, 1979, 
as cited in Sandler et al., 1988). Eight centers gathered data on 1082 visits by 89 patients. 
At each visit, information on the variables that make up the CDAI score, as well as a 
physician rating of disease activity were recorded. The physician rating was used as the 
dependent variable in a regression analysis, and had the following categories: 1 (very 
well); 3 (fair to good); 5 (poor); and 7 (very poor).
To reach their goal of developing a self-report survey instrument, the authors did 
not use the independent variables from the CDAI that required an examination or 
labwork. The remaining variables were liquid stool frequency, well-being, abdominal 
pain, use o f opiates for diarrhea, and body weight. Several data sets of 89 observation
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each were formed by randomly selecting one visit from each of the 89 patients. The 
authors then carried out “informal examinations of regression results” (p. 454), and 
decided to keep only the following independent variables; the number of liquid stools in a 
week, amount o f abdominal pain, and general well-being
One hundred samples of 89 visits (one randomly chosen visit per subject) were 
then generated For each of the three variables, partial regression coefficients were 
calculated for predicting the CDAI score. To facilitate interpretation of their scale, the 
authors multiplied these coefficients by a constant, so that the mean (138.4) and standard 
deviation (97.2) of the scale were comparable to the CDAI.
To test the utility o f the CHI, it and the CDAI were used to calculate activity 
scores for each of the 1082 patient visits. These scores were divided into quartiles, and 
the agreement between the quartiles o f each index was quantified. Another 100 random 
samples o f 89 visits, one from each patient, were then generated. An activity score was 
calculated using each index, and the Pearson correlation coefficients between the CDAI 
and the CHI were calculated. The sensitivity of the CHI was also examined by 
determining its and the CDAI’s baseline score as a quartile. The agreement between the 
instruments (e.g., higher quartile, same quartile, lower quartile) on subsequent visits was 
then examined. The authors found that when each index was used to place patients into a 
quartile, the agreement between the two was 64% (Kappa=.517). Agreement within one 
quartile was 94% (Kappa=.838), which was reported as very high.
Using all 1082 visits, the correlation between the scores of the two instruments 
was .866 (p<0001). In approximately 61% of the cases, the CHI and the CDAI were in 
agreement (by quartile) about change in disease activity. Agreement within one quartile
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occurred 97% of the time. The authors acknowledged that, because the CHI was not 
validated with an independent sample, their results could be biased. However, they 
concluded that the CHI is promising in survey research because o f its simplicity, its high 
correlation with the CDAI, and its sensitivity to change.
Drossman et al. (1991) used the CHI to survey 320 patients with ulcerative colitis 
and 671 patients who had Crohn’s disease as part o f a study o f HRQOL. In addition, 
Irvine, Zhou, & Thompson (1996) used the CHI to quantify disease activity in 45 patients 
with ulcerative colitis and 150 who had Crohn’s disease in a validation study of a 
shortened form of a HRQOL instrument. In the CHI, the subject’s responses are 
multiplied by three different values (three for the number o f loose stools, ten for 
abdominal pain, and eight for general well-being) and then added together, producing 
scores that range from 0-650. Scores less than 150 indicate that the disease is in 
remission. The CHI has only three questions, and takes less than five minutes for the 
patient to complete.
Objective vs. Subjective Measures o f  Disease Activity
The above studies reveal a debate concerning the use of objective (observed by 
the clinician) or subjective (self-reported) factors to measure disease activity. Objective 
measures o f disease activity have at least an intuitive advantage over their subjective 
counterparts. For example, a hemoglobin count is more stringently defined than “mild” 
vs. “moderate” abdominal pain. Both types o f measurements, however, appear to assess 
different, yet equally valid aspects o f disease activity Although knowing the degree of 
inflammation in the intestines is important, it does not always correspond with the
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patient’s experience o f pain or discomfort. The presence o f minimal inflammation can 
produce severe impairments in functioning and, conversely, people with highly inflamed 
intestines may report little discomfort (Goebell et al., 1990; Singleton, 1987; Talal & 
Drossman, 1995). In addition, obtaining “objective” measurements like hematocrit value 
can lead to disagreement (deDombal and Softley, 1987). The lack of a gold standard for 
disease activity validation has caused some to argue that patient ratings should not be 
considered less important in the management of IBD than the results o f lab tests (Garrett 
& Drossman, 1990). Their suggestion is to view both types of ratings as complementary, 
each adding important information for diagnosis, because any particular activity scale 
describes only a certain aspect of the disease.
However, both types of scales have also been criticized as failing to provide 
important information about the patient’s perception of functioning outside the realm of 
his/her physical symptoms. The awareness that IBD affects more than just a person’s 
bathroom habits and that it extends in its impact to the social and emotional domains has 
increased (Farmer, Easley, & Farmer, 1992; Guyatt et al., 1989). It has become clear that 
the current disease activity scales, while providing valuable data, fail to gather some 
important information, because even patients whose IBD is in remission (defined by their 
score on an activity scale) may have diminished satisfaction with their functioning (Love, 
Irvine, & Fedorak, 1992). This knowledge has paved the way for the formation of scales 
that measure health-related quality o f life
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Quality o f  Life and HRQOL: Background and Definitions
At this point it is necessary to discuss some o f the difficulties in defining the 
construct o f HRQOL. First, however, the more general concept of quality o f life (QOL) 
will be examined. Musschenga (1997) points out that QOL became an important 
consideration in medicine after certain interventions, such as the administration of 
antibiotics, were discovered. These treatments led to the prolonging o f life, but 
sometimes in a diminished capacity compared to pre-illness ftmctioning. Because 
different treatments have differential efficacy and side effects (kidney transplantation vs. 
kidney dialysis, for example), other considerations than simply whether the patient would 
survive became important. Quality o f life is now considered an important outcome in 
medicine, as evidenced by the development of measuring scales for quality o f life in 
illnesses such as cancer, asthma, epilepsy, rheumatoid arthritis, angina, diabetes and 
AIDS (Bowling, 1995).
Despite the importance o f knowing how a treatment will affect a person’s life, 
there has been great difficulty in formulating a definition of QOL (Anderson and 
Burckhardt, 1999; Farquhar, 1995). Farquhar has suggested that one reason for this lack 
of consensus is that many different disciplines are interested in the construct, each 
employing a definition that captures the components most interesting to them. Related to 
this reason, different standards o f QOL such as objective (number of hours worked) or 
subjective (enjoyment of activities) are often used across and within disciplines.
Using the term QOL without consistency makes comparing different studies 
difficult, and it can be confusing when terms such as functional status are used 
interchangeably with QOL. Anderson and Burckhardt (1999) defined functional status as
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
17
“individuals’ abilities to meet their basic needs, fulfill roles and maintain well-being (p. 
302),” and they add that, although functional status influences QOL, it does not serve as a 
synonym for it.
Based on a literature review, Farquhar (1995) described three types o f QOL 
definitions. The first type is the global definition, which includes all possible areas of a 
person’s life, fi-om family to work, health, and emotional life. Also included in this 
definition is the concept o f happiness vs. unhappiness. Farquhar provides an example of 
a global definition: “the degree of satisfaction or dissatisfaction felt by people with 
various aspects of their lives (p. 503).” Although all areas o f a person’s life are included 
in this definition, it is unclear both how to operationalize it and what areas of a person’s 
life are particularly important.
Component definitions, the second type, include only certain dimensions that are 
claimed to be central to QOL, such as freedom of choice and emotional well-being. An 
advantage to this approach is easier operationalization and measurement. A downfall, 
however, is that the dimensions are chosen arbitrarily, based on the interests of the 
researchers.
Finally, focused definitions are those that use only one or a few components of 
quality o f life, rather than claiming to measure the entire construct. The most common 
example is those addressing the component of health. Faruhar (1995) suggests that, when 
this approach is used, it is least confusing when there is explicit acknowledgement that 
only a part o f QOL is being addressed—hence the term HRQOL.
Based on these definitions, it is clear that HRQOL is a focused definition that is 
not intended to encompass all aspects of a person’s experience. Before providing a
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specific definition o f HRQOL, however, it should be noted that this construct has been 
criticized. Anderson and Burckhardt (1999) disagree with the assumption, central to 
HRQOL, that “people make distinctions between some part o f their life that is influenced 
by health, and some parts that are not so influenced (p. 302).” They suggest that, in most 
studies, the term is simply composed of variables related to the disease of interest (i.e., 
physical symptoms).
Although this criticism may have some validity, it is also clear that an illness will 
impact some areas o f a person’s life more than others (e.g., occupational role vs. family 
relationships). In addition, because quality o f life includes a potentially infinite number 
of components (Farquhar, 1995), restricting the definition to include only those areas 
most affected by the illness (HRQOL) not only allows for more accurate measurement, 
but also for the promise of utility to patients who are choosing between alternative 
treatments. These considerations lead to the following definition of HRQOL: “the 
functional effect o f an illness and its treatment on a patient, as perceived by the patient” 
(Ferry, 1999, p.S15). Note here that “functional effect” does not mean the same thing as 
functional status, but refers to a global effect on a person’s life. Based on this definition, 
two points should be noted.
First, HRQOL refers to a person’s subjective experience of IBD, as opposed to 
various laboratory measures that a patient is not directly aware of, such as hemoglobin 
count, platelet count, or eiythrocyte sedimentation rate (Guyatt, Mitchell, Irvine, Singer, 
Williams, Goodacre, & Tompkins, 1989). Second, the experience of HRQOL goes 
beyond the physical symptoms of IBD (diarrhea, pain, etc.) to its impact on other areas of 
a person’s life (Maunder, Cohen, McLeod, & Greenberg, 1995). A basic premise of this
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article is that, until recently, HRQOL has largely been ignored in IBD research. Based on 
this view o f HRQOL, several instruments designed to measure this construct will be 
described. First, however, three types of HRQOL instruments will be discussed.
Criticisms o f  Global and Generic HRQOL Instruments
Health-related quality o f life measurements can be classified as global, generic, or 
disease-specific (Irvine, 1997). Irvine states that global assessments may give an overall 
description o f a patient’s ftmctioning, but they fail to describe specific areas of 
impairment. In addition, these measures often yield only categorical scores, such as 
good, fair, or poor. Generic questionnaires, by contrast, produce a quantitative score, and 
can be used in a variety o f patient groups.
Irvine (1995), however, criticized generic HRQOL instruments by stating that 
these measures are subject to systematic error due to possible differences between the 
populations that are sampled. For example, patients with inflammatory bowel disease 
tend to be younger and have more mobility than do arthritic patients, and socioeconomic 
and marital statuses between them may also differ. Thus, differences in scores between 
the two groups may be due to factors other than health status, such as age
In addition, generic instruments can be insensitive to differences within a single 
population. Irvine (1997) described a study in which a generic HRQOL questionnaire did 
not discriminate between ulcerative colitis patients who had undergone surgery and a 
group o f healthy controls (Provenzale, Fhillips-Bute, & Shearin, 1995). As an alternative 
to global and generic HRQOL scales, Irvine recommends the use of disease-specific 
questionnaires—those designed for use in a particular group o f patients.
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The IBDQ—A Disease-Specific HRQOL Instrument
Recognizing the weaknesses of global and generic questionnaires, several groups 
have developed HRQOL instruments specific to IBD. The widely used Inflammatory 
Bowel Disease Questionnaire (IBDQ; Guyatt et al., 1989) was designed to be an outcome 
measure in clinical trials. This measurement will be used in this study, and it is described 
in detail below.
The first step in the development o f the IBDQ was the formation of 150 items that 
described problems faced by IBD patients (Mitchell et al., 1988). These were generated 
through an open-ended questionnaire administered to several doctors and clinicians, and 
to 77 patients from outpatient settings. Patients who had proctitis alone, or who had 
ileostomies, were excluded from this rating procedure. In their description of this 
process, the authors stated that the items formed five different dimensions: bowel 
symptoms, systemic symptoms, functional impairment, social impairment, and 
disturbances of emotional function. They did not, however, describe the way that these 
dimensions were formed.
The 150 items were then rated by 97 IBD patients (43 with ulcerative colitis and 
54 with Crohn’s disease) according to importance (“not very important” to “extremely 
important”). This produced a reduced list of 30 items. After additional feedback from 
several clinicians, two more items were added. These 32 questions form the IBDQ, 
which can be completed in approximately 20 minutes. Scores for each item range from 1 
(worst function) to 7 (best function), for a range o f 32-224, In Crohn’s patients who are 
experiencing remission, the average IBDQ score is 169 (Irvine, 1997). A similar score
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(174) has been reported for patients with ulcerative colitis (Han, McCoII, Steen, Barton,
& Welfare, 1998). These compare to a mean score of 211 for individuals without IBD 
(Irvine et al., 1994).
In a separate study, Guyatt and colleagues (1989) tested the validity and reliability 
o f the IBDQ. They described four subscales into which the IBDQ was divided, but did 
not describe the process used to form these sub scales. The first subscale relates to bowel 
disturbances and has ten items. It asks questions such as, “How often in the last two 
weeks have you been troubled by cramps in your abdomen?” The second sub scale 
inquires about systemic symptoms—physical symptoms not directly related to the 
gastrointestinal tract— and contains five questions. An example is, “How much energy 
have you had in the last two weeks?” The emotional function sub scale contains 12 
questions, such as, “How often during the last two weeks have you felt frustrated, 
impatient, or restless?” Finally, the social function sub scale has five questions, such as, 
“How often during the last two weeks have you had to cancel a social engagement 
because o f your bowel problem?” Considering the above discussion of conceptual 
difficulties associated with HRQOL, the IBDQ operationalizes HRQOL by referring to 
the physical, emotional, and social effects of IBD. A possible criticism at this point is a 
confounding o f physical symptoms with HRQOL Below, the IBDQ will be compared to 
three other instruments designed to measure HRQOL in IBD
Guyatt et al. (1989) then administered the IBDQ to 61 patients with IBD (38 with 
ulcerative colitis, 23 with Crohn’s disease) from both inpatient and outpatient settings to 
establish an average baseline score. They readministered it to them one month later to 
obtain a follow-up score. After the second administration, the subjects were divided into
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two groups based on their self-reported change in disease activity. The 19 patients who 
reported no change in disease activity were referred to as the stable group. The unstable 
group was composed o f thirty-three patients who reported improvement, and nine who 
said that they had deteriorated. To determine the IBDQ’s reliability, the scores of the 19 
stable patients (whose disease activity had not changed) were examined.
Guyatt et al. (1989) did not report a test-retest correlation for the scores of the 19 
stable patients. Instead, they calculated the average differences between baseline and 
follow-up for each subscale. They then calculated the standard deviations of these 
differences. The standard deviation for each subscale was then divided by that subscale’s 
average score (baseline plus follow-up divided by two), which yielded a coefficient of 
variation for each sub scale. These coefficients were: bowel symptoms, .07; systemic 
symptoms, .15; emotional function, .11; and social function, .06. No coefficient was 
reported for the IBDQ total score. The authors claim that, compared to other 
questionnaires, these are relatively small coefficients (Guyatt, Thompson, & Berman, 
1985, as cited in Guyatt et a i, 1989) and conclude that the IBDQ is a reliable instrument.
The IBDQ’s responsiveness (sensitivity to change) was tested by comparing the 
average difference score (baseline minus follow-up) for each subscale in the unstable 
group to the average difference score in the stable group. The average difference score 
for each subscale in the unstable group was divided by the standard deviation of the 
difference scores of the corresponding subscale in the stable group. For example, the 
average difference score o f the bowel subscale in the unstable group was 11.1 points and 
the standard deviation o f the bowel subscale in the stable group was 3.7. The resulting 
ratio, (11.1/3.7=3.0) is a z-score. The authors explained that, because the number of
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subjects (nine) whose disease activity had deteriorated was too small for a separate 
analysis, the sign o f their difference scores (baseline minus follow-up) was reversed.
Their scores were then included with the 33 patients whose scores had increased, for the 
analysis just described.
The ratios for the other scales were: systemic symptoms, 1.8; emotional function, 
1.4; and social function, 1.7. The authors claim that, since this ratio is greater than 1.0, 
the IBDQ is a responsive measure. Guyatt et al. (1989) note, however, that the IBDQ 
was more responsive to changes in HRQOL in ulcerative colitis patients than it was in 
Crohn’s disease patients. The responsiveness of the IBDQ in Crohn’s patients will be 
discussed below.
Guyatt et al. (1989) also reported on the IBDQ’s validity. Convergent evidence 
(Messick, 1980) for its validity was looked for in the 42 subjects with changes in the self- 
reported global rating of disease activity. Some of the notable results follow. The 
correlation between the patient’s global rating of change in tiredness and change in the 
systemic subscale was .36 (p< 05). The correlation between the patient’s global rating of 
change in emotional function and change in the emotional subscale was .52 (p<.05). The 
correlation between the change in the emotional function sub scale o f the Rand 
questionnaire (a generic measure o f physical and emotional functioning; Ware, Brook, & 
Davies-Avery, 1980) and change in the emotional subscale was .76, (p< G5). Finally, the 
patients’ global rating o f change in disease activity related moderately well with the 
changes in the bowel subscale o f the IBDQ (.42, p<.05). No correlations concerning the 
IBDQ’s social functioning scale were reported.
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As mentioned above, the IBDQ was not as responsive to changes in HRQOL in 
Crohn’s disease patients as it was in ulcerative colitis patients. To assess this aspect of 
the IBDQ in the former group in greater detail, Irvine et al. (1994) described data from a 
study o f 305 Crohn’s patients at 11 different hospitals (Archambault et al., 1991). These 
patients were randomly assigned to a group receiving either low-dose cyclosporin or a 
placebo. Subjects were administered the IBDQ and two measures of disease activity— 
the Crohn’s Disease Activity Index (CDAI; Best et al., 1976), and the Harvey-Bradshaw 
index (HB; Harvey & Bradshaw, 1980)— at two-month intervals for eighteen months. In 
addition, subjects and physicians made global assessments o f changes in patient bowel 
function, emotional function, and tiredness at each visit. These assessments were made 
on a one (a great deal worse) to seven (a great deal better) scale.
To assess responsiveness, Irvine et al. (1994) divided the patients into two groups; 
those who experienced a relapse in disease activity during the trial (171 patients), and 
those who remained stable (134 subjects). Relapse was defined as an increase of 100 
points in the CDAI and a change in steroid therapy. Two measurements, the baseline 
score and the lowest score obtained in the trial, were then compared.
The authors reported that the patients who relapsed had low scores (lowest 
obtained in the trial) that differed significantly from patients who had stable disease 
activity; that is, the IBDQ total score decreased more in patients whose disease activity 
worsened than in stable patients. This fact gives evidence for the IBDQ’s responsiveness 
in Crohn’s patients. In addition, the bowel and systemic subscales were more responsive 
than the emotional and social subscales, causing the authors to suggest that the latter 
scales measure something different than the first two scales.
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The authors stated that there is not a gold standard of HRQOL against which they 
could compare the IBDQ. In lieu of such a standard, they predicted that the disease 
activity measures would correlate more highly with the bowel subscale than with the 
social and emotional function subscales; no prediction was made concerning the systemic 
subscale. Correlations were reported between the IBDQ and the activity indices at the 
time o f initial measurement (all were significant). The correlation between the IBDQ 
overall score and the CDAI was -.67; thus a higher HRQOL score was associated with 
lower disease activity. As predicted, the emotional and social function subscales had 
lower correlations (-.50 and -.56, respectively) with the CDAI than did the bowel 
sub scale (r= - .71). The same pattern was observed between HB scores and the IBDQ 
total and dimensional scores. The authors did not state why predictions were not made 
concerning the systemic subscale.
Reliability data in this study were reported in terms o f intraclass correlation 
coefficients between IBDQ baseline scores and scores at week 8. The correlations were 
as follows; IBDQ total score, .70; bowel subscale, .65; emotional subscale, .65; systemic 
subscale, .65; and social subscale, .67. These coefficients were calculated from subjects 
with both stable and unstable disease activity, and were much higher than the patient and 
physician global reports (.09 and -.05, respectively). The authors conclude that the IBDQ 
is a valid and reliable measure of HRQOL.
A more recent study of the psychometric properties o f the IBDQ was conducted 
by Han, McColl, Steen, Barton, and Welfare (1998). They randomly selected 38 patients 
with ulcerative colitis from a hospital outpatient database, of which 28 (74%) completed 
the study. The subjects were administered the IBDQ three times in a one-month time
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period (each completion was separated by two weeks). On the first and third 
assessments, the IBDQ was given in an interview. The second administration was self­
completed. The average age o f the patients was 54 years, and all but two had ulcerative 
colitis that was in remission.
The average IBDQ score was 174, indicating that this group had relatively high 
HRQOL (Irvine et al., 1994). There were no score differences between subjects who 
were above the average age with compared those below it on any o f the IBDQ subscale 
scores. The average item-total correlation for the IBDQ was .67. The Cronbach’s alphas 
for the subscales were as follows: bowel, .81; systemic, .72; emotional, .89; social, .89 
An alpha coefficient was not reported for the IBDQ total score. The authors reported that 
the internal consistency for the subscales was similar whether the IBDQ was interviewer- 
or self-administered.
Intra-class correlation coefficients between the three administration times were 
also calculated to assess the test-retest reliability o f each subscale. Correlations between 
the interviewer- and self-administered scores ranged from .73 to .93. Correlations 
between the two interview-obtained periods were slightly lower, with intra-class 
correlations ranging from .62 to .79. The lower correlations between the interviews may 
reflect actual changes in HRQOL, however, as they occurred one month apart from each 
other. Across all three administrations, the test-retest correlations were: bowel, .79; 
systemic, .71; emotional, .79; and social, .88.
To summarize, the IBDQ subscales have high internal consistency and test-retest 
stability. The test-retest correlation o f the IBDQ total score is also high, but its internal 
consistency has not been reported. Although validity research is limited, the subscales
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are related to disease activity and to other self-reported measurements in a theoretically 
consistent fashion. The IBDQ is convenient for research use, requiring a subject 
approximately 20 minutes to complete.
Other Health-Related Quality o f  Life Scales
Other groups have designed HRQOL instruments for IBD patients. Before 
describing them, however, it should be noted that they differ from the IBDQ in different 
respects, an example o f the intra-disciplinary variance in conceptual definition that was 
noted above (Farquhar, 1995). Despite these differences, however, an important 
similarity remains: an interest in the effects o f IBD on various aspects of the lives of the 
patient, as rated by the patient.
The first group. Farmer, Easley, and Farmer (1992), designed their questionnaire 
to assist physicians in their management of IBD symptoms. Four areas of daily living are 
investigated with this measure. The Functional/Economic category assesses the ability to 
function at work, school and home. Satisfaction with personal relationships and 
recreational activities is measured by the Social/Recreational subscale. Attitude (positive 
or negative) toward the future and life in general is measured by the category called 
Affect/Life in General. Finally, Medical/Symptoms relates to physical symptoms and 
health-related behaviors. The way in which these subscales were formed was not 
described. This scale is similar to the IBDQ in its inclusion o f scales addressing physical 
symptoms and emotional and social functioning, but it also includes attitude toward the 
future. In addition the patient’s ability to function is addressed, leaving this questionnaire 
open to the criticism— discussed above—of confounding HRQOL and functional status.
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The instrument has 18 questions, and takes 15-20 minutes to administer. Each question is 
rated from one to five for a maximum score of ninety, with higher scores representing 
better functioning.
To choose the items of this instrument, the authors administered a 47-question 
interview to 70 outpatients with Crohn’s disease and 94 who had ulcerative colitis. These 
patients were classified into two groups, surgical and nonsurgical, for a total of four 
patient groups. A two way (Surgery by Disease Type) ANOVA was conducted on the 
total scores o f each patient group. F-tests o f significant (p< 01), or what were referred to 
as marginally significant values (p=.01 to .05), were reached for 18 of the 45 questions, 
which were used for the final version o f this instrument.
The authors assessed reliability by readministering the 45 questions to 23 patients, 
two weeks after the initial interview, and they reported that the Spearman correlation 
coefficients were between .75 and .95, The correlations for the final 18 questions, 
however, were not reported. The authors stated that patients with Crohn’s disease had 
impaired HRQOL compared to patients with ulcerative colitis. Having surgery was also 
related to a poorer score, and those who had surgery and Crohn’s disease had the worst 
scores of all. No other data concerning validity was given.
Martin, Leone, Fries and Naccarato (1995) developed a HRQOL scale similar to 
the IBDQ for use in the physician management o f IBD, as well as an outcome measure in 
clinical trials. Like the IBDQ it has four scales (intestinal, systemic, emotional, and 
social), and like the IBDQ it can be criticized for confusing HRQOL with physical 
symptoms. Martin et al ’s instrument consists o f 29 questions, each o f which is rated 
from 0 (never or hardly ever) to 3 (always or nearly always). Scores range from 0-87,
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with higher scores indicating worse functioning. Patients can complete the questionnaire 
in about 10 minutes.
To determine the questionnaire’s reliability, 23 patients with IBD were given the 
test twice in a two-week period. The average scores and standard deviations for the two 
administrations were 19.6 ±13.6 and 16.8+12.6. The authors stated that that the variation 
(15%) was not significant, but did not report the statistical test used to ascertain this. The 
validity o f the questionnaire was determined by giving it to 72 healthy controls and to 
112 patients (57 with ulcerative colitis and 55 with Crohn’s disease). The Crohn’s 
Disease Activity Index (Best, et al , 1976) and Truelove and Witt’s (1955) index were 
used to classify the patient’s disease as in remission, mild, or moderate/severe. The 
authors reported that patients with ulcerative colitis in remission had significantly higher 
scores (diminished function) than the controls. Similarly, patients with mild disease 
activity scored significantly higher than those who were in remission. Those with 
moderate/severe disease activity scored higher than those with mild disease. The same 
pattern was obtained for patients with Crohn’s disease. Again, the authors did not report 
the statistical test that was used.
Finally, Drossman, Lesserman, Li, Mitchell, Zagami, and Patrick (1991) have 
developed the Rating Form of IBD Patient Concerns (RFIPC). It is a 25-item, self­
administered questionnaire that contains concerns expressed by IBD patients that were 
gathered through both informal and semi-structured interviews. The RFIPC asks 
questions such as, “How concerned are you with the effects o f your medication?”
Patients respond to the questions using a visual analog scale that ranges from 0 (not at all 
concerned) to 100 (very concerned). In addition to scores for individual items, an
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average score for ail items (Sumscore) is calculated. This instrument appears especially 
susceptible to the criticism that it merely measures an emotional component of HRQOL, 
namely, worries or concerns. It differs from the HRQOL scales described above by not 
including separate scales that purport to address different aspects o f HRQOL.
The RFIPC was administered to 62 IBD patients, and had a test-retest correlation 
of .87 for the Sumscore and an average correlation o f .65 for the individual items. It was 
then administered to over 900 IBD patients (320 with ulcerative colitis, 671 with Crohn’s 
disease). A factor analysis on the 25 items yielded four factors with Eigen values greater 
than 1.0; impact of disease; sexual intimacy; complications of disease; and body stigma. 
The Cronbach’s alpha coefficients for these four indices ranged from .79- 91.
Evidence for the RFIPC’s construct validity was found in the differences in 
concerns between Crohn’s and ulcerative colitis patients. Those with Crohn’s disease 
worried more about pain and suffering, energy level, and being a burden on others. 
Ulcerative colitis patients, however, reported more concerns related to developing cancer, 
Drossman et al. (1991) note that these concerns relate to clinical differences between the 
two diseases in symptom intensity and risk of cancer.
O f the above HRQOL scales, the most work has been done concerning the 
IBDQ’s validity. In addition, researchers have been more concerned with showing the 
reliability o f the IBDQ, which may be due to the IBDQ’s introduction as an outcome 
measure in clinical trials. Despite the popularity o f the IBDQ, however, several different 
scales have been designed to measure an important component to the experience of 
IBD— health-related quality o f life. It is not clear, however, that they are all measuring 
the same construct. Although the IBDQ and scales designed by Farmer, Easley, and
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Farmer (1992) and Martin et al. (1995) have similar scales, they are not identical. In 
addition, the RFIPC (Drossman et al., 1991) appears to focus on the emotional impact of 
IBD. Thus, similar to the disease activity scales, no “gold standard” exists for HRQOL in 
IBD. However, the extensive work and favorable results on the IBDQ make it the best 
candidate for exploratory work for factors that are related to HRQOL in this area of 
study.
Research Concerning HRQOL in IBD Patients
Early studies of HRQOL in IBD patients examined how the disease affected 
various aspects o f their lives. Joachim and Milne (1987) questioned 80 people with IBD 
and observed that they reported a number of illness-related perceptions that often go 
unnoticed by physicians. Forty percent of their subjects reported that having IBD 
lessened their overall satisfaction with life, and contentment in areas such as 
relationships, recreation, and sexuality was diminished. Although this study lacked a 
control group, it demonstrated that the impact of IBD extends beyond its physical 
symptoms.
Drossman, Patrick, Mitchell, Zagami, and Appelbaum (1989) investigated the 
relationship between disease activity, HRQOL, and utilization of health care. Compared 
to a control group, IBD patients had more trouble in the areas of work, recreation, social 
interaction, emotional behavior, and sleep and rest. Patients suffering from Crohn’s 
disease reported more overall maladjustment than patients who had ulcerative colitis. A 
patient’s HRQOL score predicted the use of health services better than did a physician 
rating o f disease activity, which shows the impact this construct may have on behavior. 
The authors also reported that IBD patients have a number o f worries, such as needing an
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ostomy bag or surgery and developing cancer, concerns that traditional disease measures 
ignore.
Drossman et al. (1991) surveyed nearly 1,000 people with IBD. Compared to a 
control group, these patients had more dysfunction in the areas o f social contact, 
recreation, sleep and rest, and daily work. Again, patients with Crohn’s disease 
experienced more impairment, which the authors explained by their more severe disease 
activity. The authors also suggested that knowing a patient’s degree o f psychological 
distress and well-being are valuable for predicting both physician visits and 
hospitalization.
In what they referred to as the first quantitative study of its kind, Mitchell, Guyatt, 
Singer, Irvine, Goodacre, Tompkins, Williams, and Wagner (1988) attempted to ascertain 
the impact o f IBD on a number of life functions. Their subjects reported the most 
problems with areas such as fatigue, feeling run down, and the emotions of frustration 
and depression. The subjects did not report many problems relating to social and 
functional impairment. However, many subjects expressed a fear of possible surgery.
The authors recommend monitoring more than just physical symptoms in clinical trials.
In summary, although IBD impacts a person’s physical health, it also adversely affects 
his or her emotional and social functioning.
The Use o f  HRQOL Instruments as Outcome Measures in Clinical Trials
As mentioned above, health-related quality of life measures have not always been 
a part o f evaluating interventions for IBD, evidenced by a review o f surgical trials which 
revealed that only three o f ninety-nine discussed HRQOL (O’Young & McPeek, 1986).
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However, researchers have begun to include these instruments in studies that evaluate 
different surgical and therapeutic interventions. In their review article. Maunder, Cohen, 
McLeod, & Greenberg (1995) evaluated the effects o f surgery, drugs, and home 
parenteral nutrition on HRQOL. They categorized these studies according to their 
methodology and the quality o f the HRQOL measure used. Instruments such as the 
IBDQ and the RFIPC were considered more useful than those that had not demonstrated 
validity or reliability.
The authors found that the use o f measures like the IBDQ and RFIPC has 
increased in recent years. Between 1981 and 1987 only two studies used such 
instruments, while five articles utilized them between 1988 and 1994. They also reported 
that a greater proportion o f the studies in recent years have been prospective and 
controlled.
As fiirther examples o f recent interest in HRQOL, two recent drug trials for new 
treatments of Crohn’s disease have used the IBDQ as one of the outcome measures of 
drug efficacy. Yacyshyn et al. (1998) tested the efficacy of ISIS 2302, an antisense 
phosphorothioate oligodeoxynucleotide, in 20 patients with active Crohn’s disease and 
found that improved disease activity was associated with increased HRQOL. Infliximab, 
a chimeric monoclonal antibody, was approved by the FDA in 1998 for the treatment of 
steroid-dependent Crohn’s disease. A study examining its effectiveness (Targan,
Hanauer, Van Deventer, Mayer, Present, Braakman, De Woody, Schaible, and Rutgeerts, 
1997) used patients’ IBDQ scores as part of the definition o f a clinical response to the 
drug, with findings similar to that of Yacyshyn et al. (1998). The fact that the trials 
testing these new drugs are using the IBDQ gives evidence of the rising interest in
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HRQOL among those who are studying the treatment o f IBD, and they mirror the great 
interest in this subject in medicine in general (Bowling, 1995).
The Relationship Between Disease Activity and HRQOL
If  HRQOL scores are too highly related to measures assessing disease activity, 
then the usefulness o f  this additional construct is doubtful. However, the relation 
between the two is not a perfect one. Research that provides insight into this relationship 
comes either from controlled drug trials or from investigations o f HRQOL in IBD 
patients. The research that follows utilizes reliable, valid measures o f  disease activity 
Studies that use categorical disease activity scales (e g , good, fair, poor) are not 
mentioned here, due to the fact that such measures are relatively insensitive to clinical 
change (Irvine, 1995; Singleton, 1987).
Irvine et al. (1994) conducted a multi-center trial (described in detail above) 
involving over 300 patients with Crohn’s disease. To summarize, the subscales were 
differentially related to disease activity— from a correlation o f -.71 for the bowel subscale 
to a correlation of -.50 for the emotional function subscale. A figure depicting the 
distribution of IBDQ and CDAI scores revealed that for a given CDAI score, the IBDQ 
scores were scattered over roughly 80 points. Irvine et al. conclude that “the IBDQ and 
dimensional [subscale] scores are tapping domains distinct from the activity indexes” (p. 
292).
Turnbull and Vallis (1995) studied the relationship between disease severity, 
psychological factors, and HRQOL in 16 patients with Crohn’s disease and six who had 
ulcerative colitis. Disease activity was measured with the Dutch Activity Index (van
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Hees et al., 1980) and the St. Mark’s index (Poweil-Tuck et al., 1978), respectively, and 
the IBDQ was used to assess HRQOL. The authors found that disease activity alone was 
not significantly correlated with the IBDQ overall score (r= 41). However, when disease 
activity was combined with other factors, such as social interaction, recreation, and work 
role to form a single composite score, this correlation was significant (r=.53).
Vallis and Turnbull (1996) reported the relationship between disease activity, 
measured by the Dutch Activity Index (van Hees et al., 1980), and the IBDQ in 39 
Crohn’s patients. When 26 patients were readministered the measurements 
approximately four months later, the resulting correlation coefficients were significant 
only between disease activity and the IBDQ’s bowel and systemic subscales (r= -.46 and 
-.44, respectively).
The weaker correlations reported in the last two studies were probably due to the 
disease activity scales that were used. The instruments used by Turnbull and Vallis 
(1995, 1996) assessed objective parameters, such as erythrocyte sedimentation rate, 
albumin levels, and colonic appearance. The CDAI, by contrast, investigates several 
subjective factors, such as a patient’s perception o f abdominal pain and general well­
being. Because several o f the IBDQ’s questions are also related to pain and well-being, it 
is not surprising that the correlations between its scales and the CDAI were higher.
These studies indicate that HRQOL and disease severity, whether defined in 
objective or subjective terms, are related. This finding is intuitive; a very sick person is 
less able to enjoy life However, these studies also suggest that factors beyond illness 
alone determine the extent to which IBD affects an individual’s satisfaction with life.
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The following sections summarize the theoretical and empirical articles that discuss what 
these factors may be.
Theory About Factors that Influence HRQOL in IBD Patients
Garrett and Drossman (1990) drew a distinction between disease and illness, 
defining disease as a physical process that does harm to the body and that can be 
observed or inferred without asking for the patient’s perceptions (for example, by a blood 
test). Illness, however, is the patient’s experience o f disease and includes “how the 
symptoms are perceived, evaluated, and acted upon ” (p. 95). For example, someone 
might have a normal sigmoidoscopy, yet experience intense abdominal pain. The authors 
propose that health status—the interaction of disease and illness—depends on several 
factors; psychological status, coping style, social support, culture, and the presence or 
absence of stressful life events. In their model, disease activity per se is just one 
contributing factor to HRQOL.
Talal and Drossman (1995) reviewed research concerned with the relationship 
between stress and IBD symptoms. They agreed that, in addition to disease activity, a 
person’s response to IBD depends on the factors listed above (psychological status, 
coping style, social support, etc.). In addition, they claimed that the relationship between 
health status (HRQOL) and the factors contributing to it is bidirectional (e.g., poor health 
status may lead to depression, and vice versa). Given these claims, an empirical search 
for factors relating to HRQOL has promise for increased understanding and improved 
treatment. The following sections review literature investigating the influence of health
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beliefs, patient knowledge o f the disease, and satisfaction with social support on HRQOL 
in IBD patients and in other patient groups.
The Relationship o f  Health Locus o f  Control to HRQOL in Other Groups
A person who believes that his or her behavior determines health has an internal 
health locus of control, whereas someone who attributes health to factors beyond his or 
her control has an external health locus of control. Much research examining the 
relationship between health locus of control and quality of life has been published with 
patients diagnosed with breast cancer (Payne, 1992), osteoarthritis (Laborde and Powers, 
1985), systematic lupus erythematosus (Pfieffer and Wetstone, 1988), renal disease 
(Bremer, 1995), cardiac illness (Powers, 1994), and chronic pain (Crisson and Keefe, 
1988). Comparisons between these studies are difficult, however, because although 
many used the same measurement of health locus o f control (the Multidimensional 
Health Locus o f Control Scales; Wallston, Wallston, and De Veil is, 1978), the definition 
o f HRQOL has varied greatly and has often been confused with adjustment to disease, as 
is the case with the above studies. This makes clear statements about health locus of 
control and HRQOL impossible, but the studies are still valuable because they 
demonstrate that factors such as health beliefs are related to psychological adjustment. 
Because psychological adjustment is often included in the operational definition of 
HRQOL, increased adjustment is likely to be associated with more favorable HRQOL.
The above research can be summarized as having mixed results. Although some 
studies report a relationship between adjustment and internal health locus o f control— 
that is, that an internal health locus o f control predicts better adjustment—other studies
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have not confirmed this finding. In fact, some authors report that an internal locus of 
control is related to increased psychological distress (Affleck, Tennen, Pfieffer, & Fifield, 
1987).
Andrykowski and Brady (1994) suggest that these inconsistencies are due to the 
complex relationship between health beliefs and adjustment to disease. They propose 
that two variables may serve as moderators in this relationship; the control realities of the 
situation, and the degree of threat. The control realities o f the situation refer to whether 
or not a person actually has some influence over his or her illness. These realities may 
cause a person with an internal health locus o f control to experience increased depression 
when faced with a terminal illness. In addition, health beliefs become more important to 
adjustment when the perceived threat of a disease is great. To summarize, the 
relationship between health beliefs and adjustment is complex, and it is not necessarily a 
direct one. One would expect to find a similar relationship between health beliefs and 
HRQOL
The Relationship o f  Health Locus o f  Control to HRQOL in IBD Patients
Although the relationship of health locus of control to HRQOL have been 
investigated in many patient groups, no studies have assessed this relationship in IBD 
patients. Some authors have, however, examined levels of locus of control (a more 
general belief in one’s ability to control outcomes in life) in IBD patients. An internal 
locus o f control indicates a belief that one’s own actions are instrumental in determining 
these outcomes, and an external locus of control refers to the belief that “fate” or other 
people control one’s life. Engstrom (1991) compared the locus of control o f children
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with EBD to children with diabetes and to a control group. He reported that children with 
IBD had a more external locus o f control than the other groups, and that increased disease 
activity was predictive o f a more external locus of control (r= 67, p<.01). No relationship 
was found between locus of control and the presence o f a psychiatric disorder (defined by 
criteria described in the Diagnostic and Statistical Manual, third edition, revised; 
American Psychiatric Association, 1987).
Steinhausen (1982), however, reported that children with IBD have a more 
internal locus o f control than do healthy children. He acknowledged that this finding was 
contrary to findings in other illnesses, but he did not provide a clear description for the 
discrepancy. He also reported no relationship between locus of control score and severity 
of illness, which may have been due to a relatively small sample size (ten patients with 
Crohn’s disease and seven with ulcerative colitis). Subjects with psychiatric disturbance 
in this study (defined by the results of an interview) had a more external locus of control.
The above studies involved children, and did not assess health locus o f control, 
however, two other studies have examined coping patterns in adult IBD patients. While 
these did not assess health locus of control directly, they provide information about what 
kinds of coping strategies are important to these patients. The relationship of these 
strategies to health locus o f control will be discussed below. In the first study, Kinash, 
Fischer, Lukie, and Carr (1993) gathered information about coping style, personality 
characteristics, severity of depression, and disease activity from 88 patients with Crohn’s 
disease and 62 diagnosed with ulcerative colitis. Coping style was measured with the 
Jalowiec Coping Scale (Jalowiec, Murphy, & Powers, 1984).
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Kinash et al. (1993) reported that individuals in both patient groups had similar 
coping patterns, regardless o f their disease severity or the amount of depression they were 
experiencing. The three most commonly used coping strategies for coping with EBD 
were: (1) trying to maintain control over the situation, (2) trying to see all aspects of their 
situation, and (3) gathering more information about their situation. Examples of 
uncommonly used strategies were letting someone else handle the situation, and blaming 
someone else for the problem, evidence against the notion that IBD patients have a 
passive and dependent personality style.
Satisfaction with life in general was negatively related (r= -.32, p< 05) to the use 
of coping methods designed to manage the distressing emotions caused by IBD 
(affective-oriented coping), such as using relaxation techniques to deal with anxiety. The 
use of strategies for changing one’s situation (problem-oriented coping; e.g., getting more 
information about EBD) was positively related to life satisfaction (r=.07), although this 
relationship was nonsignificant. The way in which life satisfaction was defined, 
however, was not specified. Similarly, those who engaged in affective- vs. problem- 
oriented coping strategies reported greater deterioration in relationship satisfaction with 
family and friends but, again, the way that this satisfaction was ascertained was not 
described.
In summary, the group of patients in this study appeared to benefit the most from 
coping methods aimed at changing one’s circumstances, behavior that may originate from 
a belief that their own actions largely determine their health (an internal locus o f control). 
This interpretation is supported by Steinhausen’s (1982) findings that children with IBD 
have a more internal locus o f  control than do healthy children.
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Aware of these findings, Smolen and Topp (1998) predicted that IBD patients 
would prefer problem-focused forms o f copings, those aimed at actively improving their 
situation, and that they would find these methods effective. These coping styles were 
contrasted to emotion-focused coping techniques, which are attempts to deal with the 
distressing emotions that a situation evokes. They also predicted that as problem-focused 
coping strategies increased, the patient’s well-being would increase. The authors 
investigated these predictions by administering questionnaires to 33 patients with Crohn’s 
disease and 13 who had ulcerative colitis, and they used the Jalowiec Coping Scale to 
assess the occurrence and usefulness of coping strategies. Well-being was measured by 
three subscales (mental health, pain, and energy/vitality) of the Health Status 
Questionnaire (McHomey, Ware, Lu, & Sherboume, 1994).
The authors reported that one of the two problem-focused strategies (Supportant, 
which involves making use of supportive resources) was rated the most effective by the 
subjects. The other problem focused method, Confrontive, which involves facing the 
situation, was the third most effective strategy. A finding not in accord with their 
predictions was that Optimism, an emotion-focused coping style characterized by a 
positive outlook toward the situation, was rated the second most effective strategy. When 
the self-reported effectiveness o f Optimism was entered into a regression equation, it 
accounted for 39% of the variance in rated well-being Another finding that did not 
support the authors’ predictions was that the use o f neither Confrontive nor Supportive 
coping methods was related to well-being (r= -.04 and -.24, respectively). The authors 
did not explain why these correlations were not in the predicted direction. They did point 
out, however, that the use of emotion-focused coping strategies such as avoiding the
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problem, feeling hopeless, and responding emotionally to the problem were significantly 
related to decreased well-being. These studies suggest that many IBD patients use active 
coping strategies to deal with their illness, and that certain forms o f coping strategies— 
those which do not attempt to change the situation—are related to lower levels o f well­
being. It is not clear why Confrontive and Supportive coping methods were unrelated to 
well-being. It is possible, however, that this was due to the definition of well-being that 
was used— one derived from a HRQOL measure that is not disease-specific.
Although the above studies do not directly address the relationship between health 
locus o f control and HRQOL in IBD patients, they provide good reason for studying this 
relationship using a disease-specific measure of HRQOL. The fact that IBD patients use 
coping techniques aimed at changing their situation (e.g., gathering more information) 
indicates that they believe something can be done to change their situation. That is, their 
appraisal o f the situation (something can be done to reduce the environmental stressor) 
may have influenced the coping technique chosen (Lazarus, 1992). Whether or not 
health locus o f control is related to this appraisal is a part o f the present study’s 
investigation.
Measurement o f Health Locus o f  Control
In the present study, health locus of control was measured by Form C of the 
Multidimensional Health Locus o f Control Scales (MHLC-C; Wallston, Stein, & Smith, 
1994), an 18-item questionnaire that is a variation of an earlier instrument measuring a 
person’s beliefs about his or health. The reliability and validity of the original instrument 
(Forms A and B) were described by Wallston, Wallston, & DeVellis (1978). Wallston et
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al. (1994) divided their modified instrument (by the process described below) into four 
belief dimensions.
The first dimension, labeled Internal, assesses the degree to which a person 
believes that his or her own actions determine health. The Chance scale determines 
whether a person believes that fate or luck primarily determines health, and beliefs 
regarding the control o f doctors over one’s health are measured by the Doctors scale. 
Finally, the Other People scale asks about the perceived influence of non-health 
professionals on the health of the an individual. The first two scales contain six questions 
each, and the latter each contain three. Each item is rated on a six point Likert-type scale 
ranging from one (strongly disagree) to six (strongly agree). The MHLC-C was designed 
to yield four separate scores, as opposed to one total value, and the entire instrument can 
be completed in five to ten minutes.
The questions for Form C were written to apply to any particular illness, as 
opposed to health in general. Wallston et al. (1994) claimed that by assessing more 
specific beliefs about an illness, predictions about future behavior are more accurate.
They also stated that a person’s beliefs about health in general may differ from those 
related to a specific condition. Finally, they observed that persons with specific health 
conditions may be unsure whether to answer a question such as, “If I do the right things I 
can stay healthy” as it relates to their overall health status or to their specific disease.
They reasoned that a parallel question focused more on the person’s disease such as, “If I 
take the right actions, my condition should improve ” would be less ambiguous and assess 
more specific health beliefs.
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With these observations in mind, Wallston and colleagues (1994) wrote 24 
questions, developed on the basis o f their face validity, that would be comparable to the 
original version of the MHLC Scale (Wallston et al., 1978). These items used the word 
“condition” instead of “health,” and fell into categories of Internal, Chance, and Powerful 
Others. To ascertain the reliability and validity o f Form C, studies were conducted with 
patients of five different groups: rheumatoid arthritis, chronic pain (location unspecified), 
diabetes (Type I and Type II), and two cancer groups (type unspecified). All subjects 
completed the 24-item Form C, as well as another measure of health locus of control, and 
measures o f pain, helplessness, and depression.
Before carrying out item and factor analyses for Form C, data from all five patient 
groups were combined, then the subjects were then randomly divided into two groups for 
cross-validation purposes (Sample 1: n=596 subjects. Sample 2: n=580 subjects). The 
factor analysis that was carried out on the data from Sample 1 yielded four factors: 
Intemality (eight items). Chance (eight items). Doctors (four items), and Powerful Others 
(four items). To make Form C comparable to the original, 18-question MHLC, the 
number o f items in each factor was reduced to six, six, three, and three, respectively, by 
eliminating the items with the weakest loadings. Wallston et al. (1994) reported 
reliability coefficients for the respective scales o f .85, .79, .71, and .70 in Sample 2. In 
addition, the test-retest stability o f Form C was examined in the group of chronic pain 
study. The corresponding correlation coefficients for the Internal, Chance, Doctors, and 
Powerful Others scales were .80, .72, .58, and .40, respectively (one month interval).
The validity o f Form C was assessed in several ways. In the first, the group of 
chronic pain patients received an intervention designed to change health locus of control
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beliefs (mainly by weakening beliefs in pain helplessness). After this intervention, the 
Internal scale was significantly higher, and the Chance, Doctors, and Other People scales 
decreased significantly. The authors reported this as evidence o f Form C’s construct 
validity.
Concurrent validity was investigated by comparing Form C with one of the 
original MHLC Scales (Form B). The correlation between the Internal scales of Form C 
and Form B was .59 (p<.001), and the corresponding correlation between the two Forms’ 
Chance scales was .65 (p<.001). Finally, the Doctors and Powerful Others scales of 
Form C were significantly correlated with the Powerful Others scale o f Form B (r=.55 
and .38, respectively).
Intercorrelations between the scales of Form C in Sample 2 were also reported, 
and they tended to be related in a theoretically consistent way. For example, the Internal 
and Chance scales were inversely related (r= -.19, p<.05), but the Doctors and Other 
People scales were positively correlated (r=.22, p<.05). In summary. Form C has four 
separate scales that have high internal consistency and moderate relationships to each 
other. These scales responded in a theoretically consistent way to an intervention 
designed to change health beliefs, and they are related to an earlier version of the MHLC 
Scales. In addition, the test-retest coefficients are higher for the Internal and Chance 
scales (.80 and .72, respectively) than for the Doctors and Powerful Others scales (.58 
and .40, respectively), which supports the use of the Internal scale in this study.
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The Relationship o f  Patient Knowledge o f  Disease to HRQOL in Other Groups
Having knowledge about one’s medical condition seems intuitively related to a 
person’s adaptation to illness. The importance o f such knowledge has been studied in 
conditions such as chronic pain (LeFort, Gray-Donald, Rowat, & Jeans, 1998), cancer 
(Ferrell, Ferrell, Ahn, & Tran, 1994; Taplin, Blanke, & Baughman, 1997), congestive 
heart failure (Frattini, Lindsay, Kerr, & Park, 1998), and diabetes (Glasgow, 1995). As 
will be shown below, HRQOL is one area impacted by increased patient knowledge.
LeFort et al. (1998) studied the effects of a psychoeducational program on pain, 
depression, perceived level o f disability, self-efficacy, and HRQOL in a population of 
chronic pain patients. These subjects were randomly assigned to either the program 
(n=57) or to a control group (n=53). The program topics included education about the 
physiology o f chronic pain, nutrition, coping strategies, and exercise. This intervention 
lasted for two hours per session and continued for six weeks. The Medical Outcomes 
Study Short Form-36 (SF-36; Ware & Sherboume, 1992) was used to assess HRQOL.
This scale is a generic quality o f life scale that assesses areas including physical function, 
social function, and general mental health.
The authors reported the effects o f the psychoeducational program on a number of 
outcomes, however, its effect on HRQOL will be discussed here. The Physical role. 
Bodily pain, and Vitality subscales o f the SF-36 changed significantly after treatment. In 
addition, although the mental health and social function scales did not differ significantly 
from pre- to post-test, they changed in the same direction. As discussed above, a disease- 
specific HRQOL instrument might have been more responsive to patient education 
(Irvine, 1997). The authors concluded that similar programs for increasing patient
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
47
knowledge provide promise for increasing HRQOL in chronic pain patients and that they 
deserve further research.
The Relationship o f  Patient Knowledge o f  Disease to HRQOL in IBD Patients
This finding suggests that increasing a patient’s information about IBD can also 
raise his or her HRQOL. Although this relationship has not been well-studied in IBD 
patients, some research has been reported. Moser et al. (1995) assessed HRQOL using 
the Rating Patient Form of IBD Concerns (RFIPC; Drossman et al., 1991) in 72 patients 
with Crohn’s disease and 33 ulcerative colitis patients. Disease activity was classified as 
severe/moderate or moderate using the CD AI (Best et al., 1976) and the Colitis Activity 
Index (Rachmilewitz, 1989), and patient knowledge was measured by a visual analog 
scale (0, totally uninformed to 100, very well informed) that subjects used to estimate 
their knowledge about IBD
The authors reported that the correlation between disease activity and HRQOL 
was not significant. They did, however, find a significant correlation between the 
Sumscore of the RFIPC and estimated disease knowledge (r=-.20). Thus as knowledge 
about IBD increased, worries about the illness decreased. A weakness of this study is the 
lack o f an objective measure of patient knowledge, however, the results suggest that more 
knowledge o f IBD increases adjustment to it.
Smart, Mayberry, Calcraft, Morris, & Rhodes (1986) gave 175 patients with 
Crohn’s disease an information booklet on topics such as the symptoms, etiology and 
treatment of their illness. One year later, the 125 who could be reached and who had read 
the booklet were asked for their impressions o f it. Eighty-two percent reported that the
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information was valuable, and nearly as many said that they had learned more about 
Crohn’s disease from reading it. When asked about the effects of this material on anxiety 
levels, 30% said it had decreased, 13% reported an increase, and 57% reported no 
change. Smart et al.’s (1986) study reproduces the finding that while the majority of 
patients desire more information, about 20-30% do not desire more information because 
they find it threatening (Jones, Gallacher, Lobo, & Axon, 1993; Mansfield, Tanner, & 
Branble, 1997). This majority who desire more information may find this to be an 
effective coping style (Kinash et al., 1993). Patients who wish to know more about their 
illness typically ask about topics such as causal factors, new treatments, and risks in areas 
such as conception, pregnancy or cancer (Martin, Leone, Castagliuolo, Mario, & 
Naccarato, 1992).
Measurement o f  Patient Knowledge
In this study, a patient’s knowledge about IBD was measured using the 
Knowledge Questionnaire (KQ), a patient-completed form consisting of 37 true or false 
questions (Jones et al., 1993). The KQ was designed for both Crohn’s and ulcerative 
colitis patients, and can be completed in approximately 15 minutes. The topics of the test 
include the anatomy and function o f the gastrointestinal tract, extraintestinal symptoms of 
the disease, medical and surgical treatments, and how patients can manage their disease.
A 44-question test was initially developed from a study that involved 64 patients 
with Crohn’s disease (Rees, Mayberry, & Calcraft, 1983) who listed topics that they 
desired more information about. The 44 questions, however, contained questions 
relevant to both Crohn’s disease and ulcerative colitis. This instrument was then given to
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20 consecutive patients (type of disease was not specified) at a colitis clinic. An “index 
o f difficulty” was calculated for each item by dividing the number of correct responses to 
an item by the total number of responses to that item If  the value o f this index was 
greater than .75, meaning that most patients answered the question correctly, that item 
was either changed or eliminated.
The revised 37-question KQ was then given to a different group of 30 patients, 
sixteen o f whom completed the questionnaire again four to six weeks later Test-retest 
correlations and Cronbach’s alpha were calculated from this group. In addition, a 
randomly selected group o f 56 patients from the colitis clinic (27 had Crohn’s disease and 
29 had ulcerative colitis) completed the test for the reporting of normative data.
The authors reported a Cronbach’s alpha of .84 and a test-retest correlation of .92 
for the revised KQ. The range o f test scores was 2-29, with an average score of 13.4 and 
a standard deviation o f 6. The median score for Crohn’s patients was significantly higher 
than the median score for ulcerative colitis patients (15 vs. 11, respectively). The KQ 
score was negatively correlated with age (r= -.34, p<.01), and positively correlated with 
the number of years spent in full-time education (r= 49, p<001). In addition, the median 
score of the 13 people who were members o f the National Association of Crohn’s 
Disease and Colitis was higher than the rest o f the subjects (median =21, p< 005). The 
authors conclude that the KQ is useful for assessing patient knowledge.
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The Relationship o f  Social Support to HRQOL in Other Groups
Social support, which is needed for a variety of challenging circumstances, has 
two major functions (Krol, Sanderman, and Suurmeijer, 1993). First, there is a direct 
effect o f meeting a person’s needs for affiliation. Other people also assist an individual 
in marshaling cognitive and emotional resources for coping (a buffer effect). A person 
diagnosed with a chronic disease will presumably have an increased need for both 
functions o f social support in order to experience an optimal satisfaction with life.
Krol et al. (1993) reviewed research on the effects of social support on quality of 
life in patients with rheumatoid arthritis. Although they noted that most studies were not 
adequately designed to establish a causal link between the two constructs, they concluded 
that such support is beneficial. Similarly, a review o f 25 years o f research on lung cancer 
(Montazeri, Gillis, & McEwen, 1998) ends with an exhortation for clinicians to pay 
closer attention to a patient’s emotional needs because this attention, the authors claim, 
can lead to an increased quality o f life in these patients. Studies of people with diabetes 
(Aalto, Uutela, & Aro, 1997) and chronic pain (Trief, Carnrike, & Drudge, 1995) have 
yielded similar results.
The Relationship o f  Social Support to HRQOL in IBD Patients
Since IBD is an illness without a cure— except for removal o f the colon in 
ulcerative colitis—those who suffer from it are likely to frequently rely on emotional 
support from others. Several recent studies have examined the role that social support 
plays in helping IBD patients adapt to their illness. MacPhee, Hoffenberg, and 
Ferranchak (1998) administered a generic quality o f life instrument to 18 ulcerative
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colitis patients and 12 suffering from Crohn’s disease (average age was 14 years). The 
subjects also completed a measurement of satisfaction with present social support, and a 
significant correlation between the two was reported (r=.46). The authors concluded that 
quality o f life is better predicted by perceptions of social support than by disease activity. 
Although these subjects were adolescents rather than adults, and a categorical as opposed 
to a quantitative measure o f disease activity was used, the relationship of social support 
to HRQOL in this study is clear.
In another study, Turnbull and Vallis (1995) administered the IBDQ and 
quantitative measurements of disease activity to sixteen patients with Crohn’s disease and 
to six who had ulcerative colitis, reporting a nonsignificant correlation between disease 
activity and HRQOL (r=.41). Scores from measurements of psychosocial functioning, 
psychological distress, and coping style were then combined with disease activity into a 
single variable and used to predict the total and subscale scores of the IBDQ The 
measure of psychosocial function (Sickness Impact Profile; Berger, Bobbitt, & Pollard, 
1976) included questions about a person’s social interaction and communication with 
others. The combined measurements were significantly related to the IBDQ total score 
(r=.53, p<.05); increased HRQOL was associated with higher levels of social functioning.
In a separate study. Maunder, de Rooy, Toner, Greenberg, Steinhart, McLeod, and 
Cohen (1997) administered the RFIPC (Drossman et al., 1991) to over 200 IBD patients. 
Two groups were formed; a Counseling group, composed of people who had recently 
sought or who were being referred for counseling, and a Noncounseling group, made up 
o f patients who had not received counseling within the last six months. The authors 
reported that two RFIPC items that pertained to social support, “being alone” and “being
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a burden to others,” were more o f a concern to those in the Counseling group. Assuming 
that the people seeking counseling were experiencing greater distress than those who 
were not, indirect evidence that difficulties with social support are related to increased 
distress is provided. Presumably, increasing levels of psychological distress are also 
related to decreased HRQOL (Drossman et al., 1991), thus showing a relationship 
between social support and HRQOL.
Finally, Godber and Mayberry (1988) reported on a telephone support service 
offered to members o f  an IBD support group in Nottingham, England. The phone 
counselors were IBD patients who had received a short course in counseling skills, and in 
a period o f several months, 20 patients utilized these services. The most frequently 
discussed topics were a need to talk with someone who understands the problems of IBD, 
a feeling that a person’s doctor was not interested in these problems, and feeling too 
embarrassed to discuss these problems with friends. Clearly, this group of people was 
composed o f distressed individuals who were motivated enough to seek lay counseling, 
and who may not be a representative sample of IBD patients. In addition, no 
measurements of HRQOL or social support were taken However, the importance o f 
relationships with others to these people is clear, and the above studies suggest that the 
investigation o f social support and HRQOL in IBD patients, using valid and reliable 
measures of these constructs, has promise for increased understanding of their 
relationship.
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Measurement o f  Social Support
A subject’s satisfaction with social support was measured using the six-question 
Social Support Questionnaire (SSQ6; Sarason, Sarason, Shearin, & Pierce, 1987). This 
questionnaire was designed to provide a short (it can be filled out in a few minutes) and 
psychometrically sound measure of social support. It was based on the 27-question 
Social Support Questionnaire (SSQ; Sarason, Leaven, Bash, & Sarason, 1983), which 
will be described first.
The SSQ (Sarason et al., 1983, Study 1) was designed from a list of 61 items 
concerning social support that were formed from several studies containing hundreds of 
college students. Items that had low correlations with other items were eliminated, 
reducing the SSQ to 27 items. Each question asks the subject to (a) list the people whom 
they rely on for support in certain circumstances and (b) report their satisfaction with 
these social supports, resulting in the calculation o f two separate scales. The number 
score (N) is simply the total number o f people listed. An average N score is obtained for 
an individual by dividing the total N score by 27. Each item also receives a satisfaction 
score (S), ranging from 1 (very dissatisfied) to 6 (very satisfied). The total S score is then 
divided by 27 to produce an average S score.
The authors administered the SSQ to 602 college students. The average N score 
was 4.25, and the average S score was 5.38. The Cronbach’s alphas of the N and S scales 
were .97 and .94, respectively. A factor analysis performed on each scale showed that a 
single factor accounted for 82% of the common variance in the N scale and another factor 
accounted for 72% of the common variance in the S scale. The correlation between the
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two scales was .34, supporting their treatment as separate concepts. The test-retest 
correlations (four-week interval) for the N and S scales were .90 and .83, respectively.
After showing that the SSQ had good psychometric qualities, the authors 
investigated its validity (Sarason et al., 1983, Study 2). The subjects were 100 male and 
127 female college students. All were administered the SSQ and the Multiple Affect 
Adjective Check List (MAACL; Zuckerman & Lubin, 1965). Four weeks later, 66 of 
these subjects (28 men and 38 women) were administered the Extraversion and 
Neuroticism scales o f the Eysenck Personality Inventory (EPI; Eysenck & Eysenck,
1968).
The authors reported significant correlations (r= -.26 to -.43) between both SSQ 
scales and the Anxiety, Depression, and Hostility scales of the MAACL for female 
subjects. Similar but weaker correlations were found for men. Thus, people with higher 
social support (measured by the SSQ) experienced lower negative affect. For females, a 
significant correlation was also reported between the N score of the SSQ and the 
Extraversion scale of the EPI. Such a relationship was not found between the S score of 
the SSQ and the Extraversion scale. For men, the results were in the same direction, but 
were not significant. This is finding makes intuitive sense, since extraverts, by definition, 
are likely to have many people to turn to.
Finally, there was a significant negative correlation among female subjects 
between the S scale of the SSQ and the Neuroticism scale of the EPI, but a nonsignificant 
relationship between the N scale o f the SSQ and the Neuroticism scale; that is, women 
who were not satisfied with their social support reported more emotional disturbance. 
Again, the results were similar, but not significant, in the group of men. These results are
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consistent with the findings—described above—that emotional distress is related to 
difficulties with one’s social support system (Maunder et al., 1997). In summary, the N 
and S scales o f the SSQ are internally consistent and stable, and are related in a 
theoretically consistent way to measures of negative affect and sociability.
The SSQ6 (Sarason et al., 1987) was designed to be a short measure of social 
support that would correlate highly with the SSQ. It is composed o f six questions from 
the SSQ, and takes less than 10 minutes to complete. These questions were selected 
using data from two studies (Sarason et al., 1987) in which the subjects were several 
hundred adults who had completed the SSQ and other measures of social support. The 
six items o f the SSQ6 were chosen on the basis o f their high average loadings following a 
factor analysis of the SSQ.
A third sample o f subjects was used for cross-validation. An SSQ-6 score was 
computed for each subject, and compared to his or her SSQ score. The correlation 
between the SSQ-6 and the SSQ Number scales was .97. The correlation between the 
SSQ-6 and SSQ Satisfaction scales was .96. The internal reliabilities for these the SSQ-6 
scales were greater than .90. The authors also computed correlations between the SSQ-6 
and several measures o f social support, which did not differ from the corresponding 
correlations involving the SSQ. The authors concluded that the SSQ-6 is a satisfactory 
measurement of social support.
Purpose and Hypotheses
A great deal of research has been done concerning the treatment of the physical 
symptoms of IBD. Only recently, however, has attention been focused on the other areas
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of functioning that it impacts—a person’s health-related quality of life. This attention has 
also increased in areas such as cancer, asthma, epilepsy, rheumatoid arthritis, angina, 
diabetes and AIDS (Bowling, 1995). Despite the increased attention to this area in IBD, 
few studies have used valid and reliable measurements to study the factors that are related 
to HRQOL in this patient group. The purpose of this study is to attempt to identify some 
o f these factors. I f  strong relationships are observed between these constructs and 
HRQOL, future research could examine these variables in a manner that permits causal 
inferences about them. A review o f research leads to the following hypotheses;
1) A person’s disease activity, health locus o f control beliefs, knowledge of his 
or her illness, and satisfaction with social support will predict his or her 
health-related quality o f life better than will disease activity alone;
2) Believing that one’s behavior is able to effect positive health outcomes will be 
positively related to increased knowledge about inflammatory bowel disease;
3) Scores on a subject’s Social sub scale of the IBDQ will be strongly and 
positively related to his or her scores on the Satisfaction scale of the SSQ6;
4) The IBDQ will have reliable subscale scores and a reliable composite score, 
and;
5) The four sub scale scores o f the IBDQ will be only moderately correlated to 
each other.
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Chapter 2 
Method
Participants
Participants were recruited from rural outpatient treatment facilities in Michigan 
and Montana by gastroenterologists with whom the experimenter was acquainted. In 
addition, subjects who responded to a posting on an Internet chat group and in an IBD 
newsletter also participated. All were patients 18 or older who had a diagnosis of either 
Crohn’s disease or ulcerative colitis that was potentially confirmable by medical records 
(although to protect anonymity, this was not done). Patients who had an ostomy bag 
were excluded from the study. Based on related research, a medium effect size was 
likely for this study; thus, to obtain a power of .80 with an alpha level of .05, 84 subjects 
would be needed (Cohen, 1992). Sixty-two subjects were actually recruited.
Materials
Demographic Questionnaire. Each subject completed a questionnaire that 
gathered information about gender, age, and type and duration o f disease. It requires 
approximately one minute to complete. See Appendix A for the Demographic 
Questionnaire.
Health-Related Quality o f Life. The Inflammatory Bowel Disease Questionnaire 
(IBDQ) was used to quantify health-related quality o f life (Guyatt et al., 1989). This 
measure has 32 items, and it takes approximately 20 minutes to complete. The
57
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development o f this instrument, as well as data on its validity and reliability, were 
described above See Appendix B for the IBDQ
Disease Activity. The Chapel Hill Index (CHI) was used to measure disease 
activity (Sandler et al., 1988). The development and characteristics of this instrument 
were described above. This questionnaire contains three questions and it can be 
completed in less than five minutes. See Appendix C for the CHI.
Health Locus o f Control. The 18-item Multidimensional Health Locus of Control 
Scale, Form C (MHLC-C) was used to measure to measure health locus of control 
(Wallston et al., 1994). This measurement was described in detail above, and it requires 
approximately 10 minutes to complete. See Appendix D for the MHLC-C
Patient Knowledge. The amount of information that a patient knows about his or 
her disease was assessed by a modified form o f the Patient Knowledge Questionnaire 
(KQ; Jones et al., 1993). Information about this measurement’s development, validity, 
reliability, and modification was given above. It has 37 items and takes about 15 minutes 
to complete. The correct responses to the KQ were not indicated in the original article, 
but were obtained by having the gastroenterologist from Montana complete it. See 
Appendix E for the KQ.
Social Support. The six-item Social Support Questionnaire (SSQ-6) was used to 
measure each patient’s satisfaction with social support (Sarason et al., 1987). Its 
development and validity and reliability information were described above. This 
instrument can be completed in approximately 10 minutes. See Appendix F for the 
SSQ-6.
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Procedure
Approval by the Institutional Review Board was obtained before this study began 
(Appendix G). Many o f the participants were recruited by a gastroenterologist or nurse 
who briefly explained the study to consecutive patients at an outpatient clinic in either 
Marquette, Michigan or Missoula, Montana during regularly scheduled visits. A packet 
containing the questionnaires was then distributed to those who both wished to participate 
and who met the exclusion criteria. Those who declined were not asked again. To 
minimize the amount o f time spent explaining the study, detailed instructions were 
included with each packet (Appendix H), and they were also printed at the top each 
instrument.
Participants who wished to participate completed the questionnaires at home, with 
a total time to read and complete the packet of approximately one hour. To ensure 
complete anonymity, the instructions stated that subjects were not to write their names on 
any of the questionnaires. Each packet contained a postage-paid, addressed envelope, 
which was mailed to the principal investigator at the University o f Montana. When the 
questionnaires were received, a number code was assigned to all questionnaires in a 
packet to prevent any possibility that they would be confused with each other. In order to 
minimize the time demands on the gastroenterologist, the campus phone number of the 
principal investigator was included in the instructions. Thus, subjects had the opportunity 
to leave their first names and a number where they could be reached if they had any 
questions.
In order to increase the sample size of this study, subjects were recruited from two 
additional sources. First, a brief description of the study was posted on an Internet
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message board, asking any interested people to respond to the e-mail address of the 
experimenter. Those who responded were then sent a more detailed message that 
emphasized the anonymity o f the study, explained the exclusion criteria, and asked—if 
they were eligible and still interested—for an address to which the study could be mailed 
via the U.S. Postal Service. When an address was received, a questionnaire pack was 
sent and the address was deleted from the computer. In addition, a brief description of 
the study was placed in an IBD newsletter (Appendix K). Interested persons responded 
with an address by either e-mail or traditional mail, and a questionnaire packet was sent 
to them. All o f these packets and the instructions were identical to the ones distributed in 
the doctor’s office.
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Chapter 3 
Results
Sample Characteristics
All data were scored and entered into a computer equipped with SPSS, then 
double-checked for accuracy in both scoring and entering. A total of 113 questionnaires 
were distributed either directly or by mail, o f which 62 (55%) were received and used for 
this study. Breaking this down according to source, thirty were received from Michigan, 
two were received from Missoula, seven came from Internet subjects, and twenty-three 
came from responders to the IBD newsletter.
Table 1 displays the sample’s demographic characteristics. Seventy-three percent 
o f the subjects were diagnosed with Crohn’s disease, and of the 59 subjects who 
indicated their gender, 43 (73%) were female. All but one were Caucasian, and the mean 
age and years since diagnosis o f the sample were similar to those reported in a recent 
study (Slonim, Bulone, Damore, Goldberg, Wingertzahn, and McKinley, 2000).
In Table 2 are the range, mean and standard deviation o f the scales and subscales. 
Most o f the scales did not appear normally distributed; however, the SSQ-6 and the 
IBDQ Social subscale were particularly skewed in a positive direction. The average 
Chapel Hill Index score was 187.8, a value equivalent to a moderate level of disease 
activity (Best et al. 1976; Sandler, Jordan, and Kupper, 1988). This score was slightly 
lower than the baseline score of subjects in a recent trial o f growth hormone therapy for 
Crohn’s disease (Slonim et a l, 2000). In two other studies the pretreatment means were 
approximately 300 (Targan, Hanauer, van Deventer, Mayer, Present, Braakman,
61
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DeWoody, Schaible, and Rutgeerts, 1997; Yacyshyn et al., 98). The average IBDQ Total 
score was 152.4, slightly lower than the “in remission” group (that is, people with a low 
level o f disease activity) means o f 169.0 and 174.0 reported by Irvine (1997) and Han et 
al. (1998), respectively.
Table 1: Demographic Characteristics of 62 IBD Patients.
Characteristic Number of Subjects
Crohn’s disease 45*
Male 10
Female 32
Ulcerative colitis 17
Male 6
Female 11
Age in years
Mean (SD) 46 (17)
Range 20-80
Years since diagnosis
Mean (SD) 15 (12)
Range 1-48
Source Number (% who responded**)
Michigan 30 (50%)
Missoula 2(18%)
Internet 7 (54%)
Newsletter 23 (79%)
* Three subjects with Crohn’s disease did not report gender
** This is the percentage of subjects from each source who mailed back a questionnaire, 
not the percentage each source contributes to the sample
The average Multidimensional Health Locus o f Control-Internal score was 
slightly higher (20.2 vs. 17.7) than it was in a sample o f arthritis patients (Wallston et al,
1994). The average Knowledge Questionnaire score was 19.0, higher than the 13.4 
reported during the test’s development (Jones et al, 1993). Finally, the mean score of 5.2
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for this sample’s SSQ-6 Satisfaction score was only slightly lower than that reported for 
the original SSQ6 (5 .4; Sarason et al., 1983). The most common sources of social 
support reported by subjects were friends (60%), parents (50%), spouses (44%), siblings 
(39%), and children (35%). Other responses were employer (8%), doctor (6%), and God 
(3%).
Table 2: Mean, Standard Deviation, Range, and Total Possible of the Scales.
Instrument Mean SD Ranee Total
CHI* 187.8 131.2 0-513 650
MHLC-I 20.2 6.7 6-36 36
KQ 19.0 5.9 9-30 37
SSQ-6 5.2 1.2 1.2-6.0 6.0
IBDQ Bowel** 49.0 12.1 17-69 70
IBDQ Systemic 20.9 7.5 7-35 35
IBDQ Emotion 55.8 16.6 22-82 84
IBDQ Social 26.7 8.0 8-35 35
IBDQ Total 152.4 40.9 59-220 224
* Higher scores indicate greater disease activity; ** For IBDQ, higher scores indicate 
better fimctioning; CHI = Chapel Hill Index; MHLC = Multidimensional Health Locus of 
Control-Internal Scale; KQ = Knowledge Questionnaire; SSQ-6 = Social Support 
Questionnaire (Satisfaction Scale)
Hypothesis One
The first and major hypothesis of this study was that disease activity, health locus 
of control beliefs, knowledge o f illness, and satisfaction with social support would predict 
a person’s HRQOL better than will disease activity alone. This was tested by first 
forcing disease activity (the Chapel Hill Index) into a regression equation in a 
hierarchical fashion (Step 1). The remaining predictors (the Multidimensional Health 
Locus o f Control-Internal scale, the Knowledge Questionnaire score, and the Satisfaction
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scale o f the SSQ-6) were then entered together as a group, and the computer was 
instructed to proceed in a stepwise fashion (Step 2). The dependent variables in the five 
resulting regression equations were the IBDQ Total score and each of the IBDQ subscale 
scores (Bowel, Systemic, Emotional, and Social).
Table 3 shows the results o f the five regression analyses. As expected, the Chapel 
Hill Index accounted for a significant amount of variance in all o f the IBDQ subscale 
scores and in the IBDQ Total score, with R-squared in Step 1 ranging from .43- 67. The 
only other significant predictor was the SSQ-6 Satisfaction scale for the Emotion 
sub scale, accounting for an additional eight percent of the subscale variance.
Hypothesis Two
The second hypothesis was that believing one’s behavior is able to effect positive 
health outcomes will be positively related to increased knowledge about IBD This was 
tested by calculating a Pearson’s correlation coefficient between the Internal scale of 
Multidimensional Health Locus of Control questionnaire and the Knowledge 
Questionnaire. The correlation coefficient (one-tailed) was not significant (r = -.16, 
P>.05).
Hypothesis Three
The third hypothesis was that the Social subscale of the IBDQ would be strongly 
and positively related to the Satisfaction scale of the SSQ-6. This was tested by 
calculating a Pearson’s correlation coefficient between the Social subscale of the IBDQ
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and the Satisfaction scale of the SSQ-6. The correlation coefficient (one-tailed) was 
significant (r =.33, p<.05), and the value of was .11.
Table 3: Regression Analyses for IBDQ Subscales and Total Score.
Bowel Subscale
Steu* Variable Entered B T P nr̂ sr* Total R=
1 c m
Constant
-.075
63.2
-10.7
40.0
.00
.00
.67= .67= .67=
Svstemic Subscale
Sten* Variable Entered B T P sri Total
1 c m
Constant
-.038
28.2
-6.8
22.1
.00
.00
.44= .44= .44=
Emotion Subscale
Sten* Variable Entered B T p pf: Sri Total R:
1 c m -.008 -6.7 .00 .43= .43= .43=
2 c m
SSQ-6
Constant
-.007
4.0
49.1
-5.8
3.0
6.2
.00
.00
.00
.37=
.14=
.29=
.08= 51=
Social Subscale
Steo* Variable Entered B T p pr= sri Total R2
1 c m
Constant
-.004
34.8
-7.9
28.2
.00
.00
.52= .52= .52=
Total Score
Sten* Variable Entered B T p pr̂ sr̂ Total R:
1 c m
Constant
-.24
197.9
-9.2
33.9
.00
.00
.59= .59= .59=
® significant at .05 level; pri = squared partial correlation; sri = squared semipartial correlation 
*In Step 1 and Step 2 the C m  was entered hierarchically, and in Step 2 the SSQ-6 was entered in a 
stepwise fashion; Cffi = Chapel m il Index; SSQ-6 = Social Support Questionnaire (Satisfaction Scale)
Hypothesis Four
The fourth hypothesis was that the IBDQ would have reliable subscale scores and 
a reliable composite score. This was tested by calculating Crohnbach’s alphas for each of
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the four subscales and for the composite score o f the IBDQ. These values were as 
follows: Bowel (.86), Systemic (.85), Emotion (.95), Social Function (.90), and Total 
score (.97). These results were higher than those reported by Han et al. (1998) for the 
EBDQ subscales. They reported the following alphas: Bowel (.81), Systemic (.72), 
Emotion (.89), and Social (.89). The alpha for Total score was not given. Appendix I 
displays the items o f the IBDQ categorized according to subscale.
Hypothesis Five
The fifth hypothesis was that the four subscale scores of the IBDQ will be only 
moderately correlated to each other. This was tested by calculating the Pearson’s 
correlations between each of the four subscales, and between each sub scale and the 
composite score. Table 4 displays these correlations, which ranged from .77 between the 
Bowel and Systemic subscales to .96 between the Emotion subcale and the Total Score. 
All o f  the correlations were significant. To date, no other studies have reported the scale 
intercorrelations of the IBDQ, although Han et al. (1998) reported an average item-total 
correlation of .67.
Table 4: Scale Intercorrelations of the IBDQ.*
Bowel Systemic Emotion Social Total
Bowel
Systemic .77 — — — —
Emotion .80 .87 — — —
Social .76 .76 .82 — — —
Total .91 .91 96 .89 —
* All correlations were significant (two-tailed)
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Back to Hypothesis One: Nonsignificant Predictors
In an effort to find possible reasons why most o f the additional predictors were 
not significant in the regression equations for the first hypothesis, several other analyses 
were carried out. First, a close look was given to the probability values o f the r-tests for 
each o f the excluded variables in the regression analyses. This was done to determine if 
the study had low power, and to ascertain whether any of the variables were approaching 
significance, as well as what their partial correlation coefficients were. Table 5 displays 
the probabilities and partial correlation coefficients of the excluded variables in each of 
the five regression equations. The probabilities ranged from .08-. 89, with an average 
value o f .49, and the squared partial correlation coefficients ranged from .00- 05.
After this, the years since diagnosis, sex and age o f the subjects were entered 
hierarchically into five separate regression equations (IBDQ subscale scores and the 
Total Score), with sex coded as a dummy variable (0=female, l^male). None of these 
three predictors accounted for significant variance in any o f the EBDQ subscales or in the 
Total score.
In the next post-hoc analysis, the Chapel Hill Index and the SSQ-6 were entered 
together into a regression equation to determine the amount o f variance in IBDQ scores 
they accounted for together. The Chapel Hill Index score and the SSQ-6 score were then 
multiplied to create an interaction score for each subject. Finally, the interaction score 
was entered into the equation to establish whether it accounted for any significant 
additional variance. This was done to determine whether the SSQ-6 was a better 
predictor of HRQOL at, for example, lower versus higher levels of disease activity. The
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Table 5: Probabilities and Partial Correlation Coefficients of Excluded 
Variables in the Five Regression Equations.
Dependent Variable Excluded Variable t* p pr** pr^
IBDQ Bowel KQ .14 .89 .02 .00
SSQ-6 -.39 .70 -.05 .00
MHLC .76 .45 .10 .01
IBDQ Systemic KQ -.69 .50 -.09 .01
MHLC .95 .35 13 .02
SSQ-6 1.2 .23 .16 .03
IBDQ Emotion KQ .19 .85 .03 .00
MHLC .50 .62 .07 .00
IBDQ Social KQ .40 .70 .05 .00
SSQ-6 1.3 .20 .17 .03
MHLC 1.5 .13 .20 .04
IBDQ Total KQ .23 .82 .03 .00
MHLC .97 .34 .13 .02
SSQ-6 1.8 .08 .23 .05
* t= t-test; ** pr= partial correlation coefficient
KQ= Knowledge Questionnaire; MHLC= Multidimensional Health Locus of Control
Scale-Internal; SSQ-6 = Social Support Questionnaire (Satisfaction Scale)
. .
same procedure was repeated for each IBDQ subscale and for the Total score Table 6 
displays the results o f the five regression equations. The Interaction score significantly 
increased the R-squared value only for the Emotion subscale (4%), and it accounted for 
approximately eight percent o f unique variance (not shown in table).
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Table 6: Interaction Between Disease Activity and Social Support.
IBDO Subscale Sten 1 fRzi Step 2 R^ increase
Bowel 67* .67* .00
Systemic .46* .48* .02
Emotion .51* .55* .04*
Social .53* .53* .00
Total .61* .63* .02
® significant at .05 level
Step 1 = Chapel Hill Index and SSQ-6 Entered; Step 2 = Interaction Score Entered
Finally, the subjects were divided into two groups based on diagnosis to address 
the possibility that the regression predictions would be supported for people with either 
Crohn’s disease or ulcerative colitis, but not in a mixed sample. To examine this 
possibility, the regression analysis was repeated separately on the 17 subjects diagnosed 
with ulcerative colitis and on the 45 diagnosed with Crohn’s disease (Table 7). The 
Chapel Hill Index accounted for more variance in all o f the IBDQ scales for the subjects 
with ulcerative colitis. The SSQ-6 also accounted for a greater portion of unique 
Emotion subscale variance in the ulcerative colitis subjects (.07 vs. .27). Finally, the 
SSQ-6 accounted for 30% of unique Total score variance in the ulcerative colitis patients, 
compared to a nonsignificant amount in the Crohn’s disease subjects. Appendix J 
displays the means and standard deviations for the scales for each group.
To determine whether the Multidimensional Health Locus of Control-Internal 
Scale (MHLC) or the Knowledge Questionnaire were approaching significance in any of 
the regression equations for the ulcerative colitis patients, the probability values and 
partial correlation coefficients for each of these excluded variables were examined (Table 
8). If  a more liberal p-value o f . 10 was adopted, the SSQ-6 and the MHLC would
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become additional significant predictors in three of the subscales. For the Bowel 
sub scale, the SSQ-6 accounted for 18% of unique variance. In addition, the MHLC 
accounted for 20% and 21% of unique variance in the Social and Total scales, 
respectively.
Table 7: Regression Analyses for Crohn’s Disease vs. Ulcerative Colitis
Bowel Subscale Crohn’s disease Ulcerative colitis
Step Variable Entered* pr® sr® Total R® nr® sr® Total R®
1 c m .59" .59* .59* .76* .76* .76*
Systemic Subscale Crohn’s disease Ulcerative colitis
Sten Variable Entered nr® sr® Total R® pr® sr® Total R®
1 c m .34* .34* .34* .62* .62* .62*
Emotion Subscale Crohn’s disease Ulcerative colitis
Sten Variable Entered or® sr® Total R® or® sr® Total R®
1 c m .37* .37* .37* .49* .49* .49*
2 c m .35* .30* .11* .03*
SSQ-6 11* .07* .44* .53* .27* .76*
Social Subscale Crohn’s disease Ulcerative colitis
Step Variable Entered pr® sr® Total R® or® sr® Total R®
1 c m .45* .45* .45* .64* .64* .64*
Total Score Crohn’s disease Ulcerative colitis
Sten Variable Entered or® sr® Total R® pr® sr® Total R®
1 c m .51* .51* .51* .72* .72* .72*
2 c m .51* .51* .50* .19*
SSQ-6 .03? t  .51* .30* .08* .80*
® significant at .05 level; f  not significant; t  not in printout; p f  = squared partial correlation; sri = squared 
semipaitial correlation; CHI = Chapel Hill Index; SSQ-6 == Social Support Questionnaire (Satisfaction 
Scale); *In Step 1 and Step 2 the CHI was entered hierarchically, and in Step 2 the SSQ-6 was entered in a 
stepwise fashion
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Table 8: Probabilités and Partial Correlation Coefllcients for Excluded 
Variables in Ulcerative Colitis Patients.
Dependent variable Excluded variable t* p pr** pr^
IBDQ Bowel KQ -.90 .38 -.23 .05
MHLC 1.7 .11 .42 .18
SSQ-6 1.8 .10 .43 .18
IBDQ Systemic SSQ-6 .36 .72 .10 .01
KQ -1.6 .14 -.38 .14
MHLC 1.7 .12 .41 .17
IBDQ Emotion KQ -.80 .44 -.22 .05
MHLC 1.0 .32 .27 .07
IBDQ Social KQ -.68 .51 -.18 .03
SSQ-6 .83 .42 .22 .05
MHLC 1.9 .08 .45 .20
IBDQ Total KQ -1.2 .23 -.33 .11
MHLC 1.8 .10 .46 .21
* p= t-test; * * pr= partial correlation coefficient
c m  = Chapel Hill Index; KQ = Knowledge Questionnaire; MHLC = Multidimensional 
Health Locus o f Control Scale-Internal; SSQ-6 -  Social Support Questionnaire 
(Satisfaction Scale)
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chapter 4 
Discussion
Hypothesis One
Social support This study confirms that disease activity is related to HRQOL, a 
finding that is consistent with previous research (Irvine et al., 1994; Vallis and Turnbull, 
1996). The major hypothesis of this study, however, was that a person’s disease activity, 
health beliefs, knowledge of illness, and satisfaction with social support would predict his 
or her HRQOL better than would disease activity alone. Possible reasons for the 
nonsignificance of health beliefs and knowledge of illness will be discussed below, but 
first the relationship o f social support to HRQOL will be discussed.
The SSQ-6 was a significant predictor for the Emotion subscale of the IBDQ 
(Table 3). This finding is consistent with research in areas such as lung cancer 
(Montazeri et al., 1998) and diabetes (Aalto et al., 1997), and it also supports findings 
with IBD patients (MacPhee et al., 1998; Maunder et al., 1997). The present study has 
refined the understanding gained by previous research in IBD, however, by overcoming 
two methodological limitations.
First, a quantitative rather than a categorical measure o f disease activity was used, 
and a disease specific rather than a generic HRQOL instrument was employed, allowing 
for a more precise description of the relationship between social support, disease activity, 
and HRQOL. Second, satisfaction with social support was measured with a well- 
validated and reliable instrument, rather than a composite score based on psychosocial 
functioning, psychological distress and coping style (Turnbull and Vallis, 1995).
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Specifically, the present study suggests that satisfaction with social support is 
related to the emotional aspect o f HRQOL in IBD (Table 3). In addition to depression, 
the Emotion scale asks about anxiety, worries related to having IBD, embarrassment, 
anger, and feeling misunderstood by others (Appendix J). This relationship suggests that 
having people to talk to about the feelings associated with IBD is important, because 
many o f the symptoms— abdominal pain and rectal bleeding for example—are 
embarrassing and could isolate a person in his or her suffering.
Based on this finding, several interventions may be helpful. Some people may 
benefit from learning communication skills specifically aimed at proper disclosure of 
symptoms. For example, a person would describe their discomfort differently to a spouse 
than to an employer. In addition, certain individuals may receive encouragement fi'om a 
support group, which could be either face-to-face or through an online chat room. 
Advantages to an online group include easy accessibility (to those with computers) and 
anonymity. Doctors who deal regularly with IBD patients would do well by being aware 
of and referring to both types o f support groups in their cities.
Health locus o f  control. Health locus o f control (HLOC) and patient knowledge 
were not significant predictors o f any aspect o f HRQOL (Table 3). In chronic illnesses 
such as osteoarthritis and chronic pain, a relationship between HLOC and psychological 
adjustment has been demonstrated (e.g., Crisson and Keefe, 1988; Laborde and Powers, 
1985). It was assumed for this study both that psychological adjustment was an aspect of 
HRQOL (Farquhar, 1995), and that the active coping methods used by some IBD patients 
(Kinash et al., 1993) are prompted by the belief that one’s actions to a large extent 
determine health.
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The negative findings of this study in regards to HLOC, however, are similar to 
the research by Smolen and Topp (1998), who did not find a strong relationship between 
problem-focused coping styles and well-being, a concept related to HRQOL (Farquhar, 
1995). Andrykowski and Brady (1994) have suggested that health beliefs become more 
important to adjustment when the perceived threat of the disease is great. It may be that 
sufferers o f IBD view their illness more as a nuisance than a great threat to their health 
It may also be the case that psychological adjustment— a vague term to be certain—is not 
an important aspect of HRQOL as defined by the IBDQ. Future research on HRQOL 
should clearly define the construct, and it should not interchange terms such as well­
being or health status for HRQOL (Anderson and Burckhardt, 1999).
Knowledge o f  illness. A patient’s knowledge of his or her illness is related to 
HRQOL in conditions such as chronic pain (Lefort et a l , 1998) and diabetes (Glasgow,
1995), and studies with IBD patients have suggested a similar link (Moser et al., 1995; 
Smart et al, 1986). The present study, however, did not offer support for the relationship 
between knowledge and HRQOL over and above the effects of the Chapel Hill Index 
(Table 3). There are at least two possible reasons for this discrepancy.
First, the symptoms o f IBD are qualitatively different than conditions like chronic 
pain. Education programs for chronic pain often teach coping techniques such as 
relaxation (LeFort et al., 1998) and present information about the physiology of pain. 
These programs are successful at addressing the physical symptoms of chronic pain, and 
have a corresponding effect on HRQOL (LeFort et al., 1998). Because of the nature of 
Crohn’s disease and ulcerative colitis, however, similar programs for IBD have not been 
successful at addressing physical symptoms (Schwartz and Blanchard, 1991). Thus,
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although knowledge may help reduce the suffering involved in chronic pain, it apparently 
has little effect on the symptoms o f IBD.
The second possibility for the discrepancy between this study and previous 
research concerning patient knowledge is that past studies with IBD patients have used 
less rigorous methodologies. Moser et al. (1995) and Smart et al (1986) reported a 
relationship between disease knowledge and HRQOL, however, they had subjects 
estimate their knowledge rather than complete an objective measure. It may be that what 
a person thinks (s)he knows and what (s)he actually knows are different. Further, Jones 
et al. (1993) reported that about 20-30% o f people do not want more information about 
IBD. Future research could examine the role o f disease knowledge on HRQOL in the 
subgroup of patients who strongly desire more information.
Hypothesis One: Additional Analyses Concerning the Nonsignificant Predictors
Although the modest contribution of social support and the nonsignificant 
contributions of HLOC and patient knowledge to HRQOL may have occurred for the 
reasons mentioned above, additional analyses were done to determine if future research 
should investigate a modified version o f the first prediction. An analysis of the sample 
(Table 2) reveals that subjects had, on the average, moderate disease activity and a 
correspondingly diminished HRQOL. On these variables, as well as for age and years 
since diagnosis (Table 1), the sample was similar to other groups reported in the 
literature. Thus, this sample appears to be fairly representative of the population of IBD 
patients, at least of those who are Caucasian. In addition, although most of this group
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was female, sex accounted for a nonsignificant proportion of variance in the IBDQ 
subscales and the Total score, as did the years since diagnosis and age of the subjects.
Despite the fact that, with a larger sample, health beliefs and disease knowledge 
may have been significant predictors, the actual amount of variance they would account 
for would likely have been quite small compared to disease activity and, to a lesser 
degree, satisfaction with social support. Whereas the values of R-squared for the Chapel 
Hill Index ranged from .43- 67 (Table 3), the squared partial correlations for health 
beliefs or disease knowledge were very small (pr^ ranged from .00-.04; Table 5), and the 
corresponding values for the SSQ-6 ranged from .00-.05. It does not appear, therefore, 
that the failure to confirm the major hypothesis was merely due to insufficient statistical 
power.
Similarly, level o f disease activity did not play a major role in prediction of 
HRQOL. With the exception of the Emotion subscale, the interaction variable (disease 
activity X social support) did not add significantly to R-squared, and it added only 4% to 
the Emotion subscale (Table 6). Thus it was not the case that the major hypothesis was 
confirmed at only certain (e.g., lower) levels o f disease activity.
The choice o f disease activity scale could have contributed to the lack of support 
for the major hypothesis. Previous research (Irvine et al., 1994) has shown that the 
Crohn’s Disease Activity Index (and thus the Chapel Hill Index) and the IBDQ Total 
score are highly correlated, most likely because both ask for subjective symptoms of IBD 
(Appendices B and C). The use o f an objective disease activity scale may have produced 
results that supported the major hypothesis.
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Beside the possibility that the null hypothesis is true, however, the most likely 
explanation for the lack of support for the major hypothesis is that grouping both Crohn’s 
disease and ulcerative colitis patients together obscured the results Disease activity was 
a better predictor for every aspect of HRQOL for subjects with ulcerative colitis and, 
similarly, social support was a better predictor for the Emotion and Total scales (Table 7). 
In addition, health beliefs approached significance in both the Social and Total scales 
(Table 8). The fact that these variables were significant or close to significant in a 
sample o f only 17 subjects strongly suggests that more research be done to examine the 
relationship o f these variables to HRQOL in ulcerative colitis patients.
This analysis, although post-hoc, is consistent with research showing that Crohn’s 
patients have diminished HRQOL compared to ulcerative colitis patients (Drossman et 
al., 1989; Farmer, Easley, and Farmer, 1992), and that the two groups have different 
disease-related concerns (Drossman et al., 1991). Although Drossman et al. (1991) 
explained the impairment in Crohn’s disease in terms o f greater disease activity, this 
study did not support that interpretation. Before concluding, however, that the lack of 
support for the major hypothesis is due to a “Crohn’s personality style,” that is, a passive 
or dependent manner o f relating to others, it should be noted that such speculation has not 
been consistently supported (North and Alpers, 1994). It may be that people with 
ulcerative colitis experience symptoms that are slightly different than those of Crohn s 
sufferers (e.g., weight loss vs. fatigue), and that they are better able to manage the impact 
that their illness has on their lives. A better understanding of this process could lead to 
interventions that would increase the HRQOL o f people with Crohn’s disease and 
ulcerative colitis alike.
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Hypothesis Two
The second hypothesis—believing that one’s behavior is able to effect positive 
health outcomes will be positively related to increased knowledge about IBD—was not 
confirmed. The original rationale for this hypothesis was that an internal HLOC may 
prompt people to learn more about their illness, or, alternatively, having a lot of 
knowledge about IBD may cause one to feel more in control of the illness. Both 
interpretations were based on Kinash et al s (1993) research showing that maintaining 
control and gathering information were commonly used coping strategies in IBD patients.
The fact that these two constructs were not related to each other is consistent with 
the finding by Smolen and Topp (1998) that a positive outlook (optimism), not more 
active strategies, is related to well-being. It may be that an interaction between optimism, 
HLOC, and knowledge of illness exists, a possibility that future research could 
investigate The data in this study, however, suggest that health beliefs and knowledge of 
illness are not related.
Hypotheses Three, Four and Five
Hypothesis Three. The last three hypotheses deal with certain psychometric 
properties of the IBDQ and, therefore, will be treated together. The third hypothesis was 
that the Social subscale o f the IBDQ will be strongly and positively related to the 
Satisfaction scale o f the SSQ-6. Such an association would help to establish the 
concurrent validity o f the IBDQ’s sub scale, which is important, because the validity of 
this scale has not yet been firmly established.
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In this study, the relationship between the two scales was a significant but 
moderate (r = .33) correlation; thus there is some support for the concurrent validity of 
the Social sub scale o f the EBDQ. Although a higher correlation was anticipated, a close 
look at the content o f the items in the two measures reveals some differences between 
them. The SSQ-6 (Appendix F) asks for a list of people who are, for example, 
dependable when help is needed, and how satisfied they are with their support. The 
IBDQ Social subscale (Appendix I), however, asks about how having IBD has limited 
one’s ability to attend social events such as school, work, or leisure activities. It is 
possible for a person with IBD to have a severely restricted social life (and a 
correspondingly low Social subscale score), yet still be relatively satisfied with his or her 
social support. This satisfaction could occur by means of an accommodating support 
system; for example, the healthy husband could stay home with his wife who is too ill 
with IBD to attend, thus preserving social satisfaction in spite of social limitations.
It is a mistake, therefore, to assume that, because a person with EBD is restricted 
in their ability to engage in activities outside the home, they are also dissatisfied with 
their social support. Acknowledging this point can lead to creative ways of increasing 
social support to individuals with severe disease activity, and it also highlights the 
importance of educating friends and family members about IBD, so that they can help the 
person with EBD compensate for their illness. Thus, the Social subscale of the IBDQ 
appears to have utility as a way to quantify how impacted a person’s social life is by IBD, 
although it may not give a clear indication o f satisfaction with social support.
Hypothesis Four. Although previous research has shown that the individual 
sub scales have sufficiently high Crohnbach’s alphas, the total score has not received this
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attention. In this study, the alpha coefficient for the total score was .97, supporting the 
use o f the composite score as a way o f providing an overall picture o f a person’s 
HRQOL
Hypothesis Five. All of the scale intercorrelations were very high, and because 
the lowest correlation was .76 (Table 4), there is some question concerning the treatment 
o f the scales as measuring separate constructs. It may be that all o f the scales measure a 
common aspect of having IBD such as depression, an emotion frequently reported by 
IBD patients (Mitchell et al., 1988). As discussed above, the Emotion subscale asks 
about depressive symptoms, such as discouragement, tearfulness and life dissatisfaction 
(Appendix I), and the Systemic subscale inquires into symptoms such as fatigue and 
sleep and appetite disturbances. In addition, the Social subscale describes diminished 
social interactions, which some researchers (Bellack, Hersen, and Himmelhoch, 1981; 
Hoberman, 1990) have linked to depression. It is at least plausible that depression could 
account for a sizeable portion of variance in all of the subscales. Future research using 
the EBDQ should include a measure o f depression such as the Beck Depression Inventory 
(Beck, Ward, Mendelson, Mock, and Erbaugh, 1961) to address this question. Until that 
is done, the utility o f using the IBDQ to discuss distinct components of HRQOL is 
uncertain.
Final Conclusion
Although this study provided some insights into HRQOL in IBD patients, it also 
raised many questions, a fact reflecting the relatively small amount of research that has 
been done in this area. (Maunder et al., 1995). Future research should begin with a clear
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definition o f HRQOL as a construct distinct from terms such as well-being and health 
status, and the use o f disease activity measures that covers both the objective and 
subjective physical symptoms o f IBD should be considered. In addition, it may be wise 
to reconsider the utility of grouping both Crohn’s disease and ulcerative colitis subjects 
together for HRQOL research, because the two groups appear to be impacted differently 
by the illnesses. Although the IBDQ is currently the best instrument for this type of 
research, its ability to define discrete zireas o f HRQOL has not been sufficiently 
demonstrated. More definite answers in this area are essential for assisting people in 
adapting to the life-changing experience of IBD
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APPENDIX A 
DEMOGRAPHIC QUESTIONNAIRE
Gender;
Age:
Ethnicity (circle one): Caucasian Hispanic African-American
Native American Other
Type of illness (circle one): Crohn’s disease Ulcerative colitis
Duration o f illness (how many years or months you have had it) :___ _
Have you ever had surgery because of your Crohn’s disease or ulcerative colitis? 
If yes, list dates:________________________________________________
Current medications and dosages (please list ALL that you are taking, even if they are not 
for Crohn’s disease or ulcerative colitis):
Medication: Dosage:
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APPENDIX B
THE INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE (IBDQ)
This questionnaire asks questions concerning the impact o f Crohn’s disease or ulcerative 
colitis on various areas o f your life. There are no right or wrong answers, so just answer 
as honestly as you can
Please indicate how you feel about each item by circling a number from 1 to 7 in the 
space provided. A 1 indicates that the area o f your life is a current difficulty. A 7 means 
that the area o f your life is not a current difficulty. (NOTE: The actual IBDQ has a card 
for each question that explains in detail what each number means).
1. How frequent have your bowel movements been during the last two weeks?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
2. How often has the feeling o f fatigue or o f being tired and worn out been a problem 
for you during the last two weeks?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
3. How often during the last two weeks have you felt frustrated, impatient, or restless? 
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
4. How often during the last two weeks have you been unable to attend school or work 
because of your bowel problem?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
5. How much of your time during the last two weeks have your bowel movements been 
loose?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
6. How much energy have you had during the last two weeks?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
7. How often during the last two weeks did you feel worried about the possibility of 
needing to have surgery because of your bowel problem?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
8. How often during the last two weeks have you had to delay or cancel a social 
engagement because o f your bowel problem?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
9. How often during the last two weeks have you been troubled by cramps in your 
abdomen?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
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10. How often during the last two weeks have you felt generally unwell?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
11. How often during the last two weeks have you been troubled because of fear of not 
finding a washroom?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
12. How much difficulty have you had, as a result of your bowel problems, doing leisure 
or sports activities you would have liked to have done during the last two weeks?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
13. How often during the last two weeks have you been troubled by pain in the abdomen?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
14. How often during the last two weeks have you had problems getting a good night’s 
sleep, or been troubled by waking up during the night?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
15. How often during the last two weeks have you felt depressed or discouraged?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
16. How often during the last two weeks have you had to avoid attending events where 
there was no washroom close at hand?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
17. Overall, in the last two weeks, how much of a problem have you had with passing 
large amounts of gas?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
18. Overall, in the last two weeks, how much o f a problem have you had maintaining, or 
getting to, the weight you would like to be at?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
19. Many patients with bowel problems often have worries and anxieties related to their 
illness. These include worries about getting cancer, worries about never feeling any 
better, and worries about having a relapse. In general, how often during the last two 
weeks have you felt worried or anxious?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
20. How much of the time during the last two weeks have you been troubled by a feeling 
of abdominal bloating?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
21. How often during the last two weeks have you felt relaxed and free of tension?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
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22. How much of the time during the last two weeks have you had a problem with rectal 
bleeding with your bowel movements?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
23. How much of the time during the last two weeks have you felt embarrassed as a result 
o f your bowel problem?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
24. How much of the time during the last two weeks have you been troubled by a feeling 
of having to go to the bathroom even though your bowels are empty?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
25. How much of the time during the last two weeks have you felt tearful or upset?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
26. How much of the time during the last two weeks have you been troubled by 
accidental soiling of your underpants?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
27. How much of the time during the last two weeks have you felt angry as a result of 
your bowel problem?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
28. To what extent has your bowel problem limited sexual activity during the last two 
weeks?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
29. How much of the time during the last two weeks have you been troubled by feeling 
sick to your stomach?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
30. How much of the time during the last two weeks have you felt irritable?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
31. How often during the last two weeks have you felt lack of understanding from others?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
32. How satisfied, happy, or pleased have you been with your personal life during the last 
two weeks?
(Current difficulty) 1 2 3 4 5 6 7 (Not a difficulty)
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APPENDIX C 
CHAPEL HILL INDEX
The following questions relate to problems caused by your Crohn’s disease or ulcerative 
colitis. Please answer the questions to the best of your knowledge. If you cannot 
remember exactly, an estimate is fine.
Answer the questions as they relate to your Crohn’s disease or ulcerative colitis, not to 
other situations in your life. For example, if your Crohn’s disease was not active, but you 
had abdominal pain due to food poisoning, you would circle “None” for Question 2.
1. In the past seven days, how many liquid or very loose stools have you had per day?
2. In the past seven days, how much abdominal pain have you had each day? (Please 
circle one o f the following):
None Mild Moderate Severe
3. In the past seven days, how would you rate your general well-being? (Please circle 
one o f the following):
Well Slightly below par Poor Very poor Terrible
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Instructions: Each item below is a belief statement about your medical condition with which you may 
agree or disagree. Beside each statement is a scale which ranges from strongly disagree (1) to stron^y 
agree (6). For each item we would like you to circle the number that represents the extent to which you 
agree or disagree with that statement. ITie more you agree with a statement, the higher will be the 
number you circle. The more you disagree with a statement, the lower will be the number you drcle. 
Please tnake sure that you answer EVERY ITEM and that you circle ONLY ONE number per item. 
This is a measure o f your personal beliefs; obviously, there are no right or wrong answers.
I =STRONCH.Y DISAGREE (SX>) 4-SUGHTLY AGREE (A)
2=M0DERATELY disagree (MD) 5HMODERATELY ACHtEE (MA) ; 
3=SUC»m,Y DISAGREE (D) 6-SniONGLY AGREE (SA) i|
Is d m d Id 'klM AlSAi
2 As to my condition, sWiat will be will be. l|4 ;| 5 '1 6 ;#
4 Most things that afreet my condition happen to  me by chance. 1 i 1 2 u _ 6
l ^ i i B
( 6  |I am directly responsible for my condition getting better or worse. ( '2 f ï 5 mm
8 Whatever goes wrong with my condition is my own faulL | 1 C I ” f ^ 4 ;  5 : 6
In order for my condidon to improve, h is up to other people to see that 
the right things happen. 1 E3 l̂iJ6 '__ '
. 11 -j 1 111
J 2 The main thing which affects my condition is what I myself do. 1 [ t 3 4 T ~ 6
:i3  _ 1 11 1
14 Following doctor's orders to the letter is the best way to keep my 
condition from getting any worse. 1 2 3 4 5 6
-,.15 IF nij^conditioii.Woriai^ ifs  i  :niatteEirf:&te;:-. Id s  1M i im E16 [f I am lucky, my condition will get better. ! I _2_ 3 4 5 A -
17, IEmy condition takes a  ttmi for foe worse,.it ia because^Fhave hot hw n / ■ 1!
i 18
i . .
I he ^ e  of help I receive from other people determines how soon my 
condition improves. 1 '
3 4 5 6
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APPENDIX E
PATIENT KNOWLEDGE QUESTIONNAIRE
The following questions relate to different topics about Crohn’s disease and ulcerative 
colitis. Read each statement and circle the response you believe is correct—T if the item 
is true, and F if the item is false. If you do not know the answer to an item, please do not 
guess; instead, circle DK (don’t know).
1. The following things may be caused by Crohn’s disease or ulcerative colitis:
5.
a. Red eyes. T F DK
b. Dry mouth. T F DK
c. High blood pressure. T F DK
d. Painful joints. T F DK
e. Anemia. T F DK
2. Concerning your bowel:
a. The large bowel connects the outlet of the stomach to the back passage.
T F DK
b. Crohn’s disease affects the small bowel only. T F DK
c. Ulcerative colitis may affect any part o f the bowel. T F DK
d. The small bowel absorbs protein from food into the bloodstream.
T F DK
e. The bowel absorbs water from drinks into the bloodstream. T F DK
3. The chances o f your children inheriting Crohn’s disease/ulcerative colitis are:
a. Very small. T F DK
b. Greater than if you did not have the disease. T F DK
c. Children of the same sex as you will probably inherit the disease.
T F DK
4. Blood tests are often performed in the colitis clinic for the following purposes:
a To check your cholesterol level. T F DK
b. To find out your blood group. T F DK
c. To help assess whether your bowel is inflamed. T F DK
d. To check whether you are short of vitamins. T F DK
Steroid tablets used in treating Crohn’s disease or ulcerative colitis: 
a. May build up muscles. T F DK
b. May cause thinning of bones. T F DK
c. May cause nosebleeds. T F DK
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6. When you are well, the following tablets are used in the long-term to prevent Crohnh 
disease/ulcerative colitis from becoming active again;
a. Loperamide (Imodium) T F DK
b. Azathioprine (Azamune, Imuran) T F DK
c. Prednisolone (steroid) T F DK
d. Ranitidine (Zantac) T F DK
e. Sulfasalazine (Salazopyrine) T F DK
f. Mesalazine (Asacol) T F DK
7. Regarding surgical operations in Crohn’s disease and ulcerative colitis:
a. Most people with Crohn’s disease will require an operation at some point during 
the course o f their illness. T F DK
b. Most people with ulcerative colitis will require an operation at some point during 
the course of their illness. T F DK
c. Following an operation, Crohn’s disease may occur again elsewhere in the bowel.
T F DK
d. Following an operation to remove the large bowel, ulcerative colitis may occur 
again elsewhere in the bowel. T F DK
e. Removing part o f the bowel can cause more frequent bowel movements.
T F DK
8. Regarding diet in Crohn’s disease and ulcerative colitis:
a. Most people with Crohn’s disease and ulcerative colitis do not need to be 
restricted to a low residue (low fiber) diet. T F DK
b. You should avoid sugary foods. T F DK
c. You need not restrict your alcohol intake because you have Crohn’s 
disease/ulcerative colitis. T F DK
d. You should avoid milk. T F DK
9. If  you should start with an episode of diarrhea you should:
a. Continue to eat as you normally would. T F DK
b. Wait a while but see your doctor if it persists for more than three weeks.
T F DK
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APPENDIX F
SOCIAL SUPPORT QUESTIONNAIRE (SHORT FORM)
SSQ6
The following questions ask about people in your environment who provide you with 
help or support. Each question has two parts. For the first part, list all o f the people 
that you know, excluding yourself, whom you can count on for help or support in the 
manner described. Give the persons’ initials and their relationship to you (see 
example). Do not list more than one person next to each o f the numbers beneath the 
question.
For the second part, circle how satisfied you are with the overall support you have. If 
you have had no support for a question, check the words “No one,” but still rate your 
level o f satisfaction. Do not list more than nine persons per question.
Please answer all o f the questions as best as you can. All o f your responses will be 
kept confidential.
EXAMPLE;
Who do you know whom you can trust with information that could get you in 
trouble?
No one 1) T.N. (brother)
2) L.M. (friend)
3) R S . (friend)
4) T.N. (father) 7)
5) L.M. (employer) 8)
6) 9)
How satisfied?
6-very
satisfied
5-fairly
satisfied
4-a little 
satisfied
3-a little 
dissatisfied
2-fairly
dissatisfied
1-very
dissatisfied
1. Whom can you really count on to be dependable when you need help? 
No one 1)
2)
3)
4)
5)
6)
7)
8) 
9)
2. How satisfied?
6-very
satisfied
5-fairly
satisfied
4-a little 
satisfied
3-a little 
dissatisfied
2-fairly
dissatisfied
1-very
dissatisfied
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3. Whom can you really count on to help you feel more relaxed when you are under
pressure or tense?
No one 1) 4) 7)
2) 5) 8)
3) 6) 9)
4. How satisfied?
6-very 5-fairly 4-a little 3-a little 2-fairly 1-very
satisfied satisfied satisfied dissatisfied dissatisfied dissatisfied
5. Who accepts you totally, including your worst and your best points?
No one 1) 4) 7)
2) 5) 8)
3) 6) 9)
6. How satisfied?
6-very 5-fairly 4-a little 3-a little 2-fairly 1-very
satisfied satisfied satisfied dissatisfied dissatisfied dissatisfied
7. Whom can you really count on to care about you, regardless of what is happening
to you?
No one 1) 4) 7)
2) 5) 8)
3) 6) 9)
8. How satisfied?
6-very 5-fairly 4-a little 3-a little 2-fairly 1-very
satisfied satisfied satisfied dissatisfied dissatisfied dissatisfied
9. Whom can you really count on to help you feel better when you are feeling
generally down-in-the-dumps?
No one 1) 4) 7)
2) 5) 8)
3) 6) 9)
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10. How satisfied?
6-very 5-fairly 4-a little 3-a little 2-fairly 1-very
satisfied satisfied satisfied dissatisfied dissatisfied dissatisfied
11. Whom can you count on to console you when you are very upset?
No one 1) 4) 7)
2) 5) 8)
3) 6) 9)
12 How satisfied?
6-very 5-fairly 4-a little 3-a little 2-fairly 1-very
satisfied satisfied satisfied dissatisfied dissatisfied dissatisfied
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APPENDIX G
Institutional Review Board Proposal
The Relationship of Health Beliefs, Knowledge o f Disease, and Social Support to Health- 
Related Quality of Life in Patients with Inflammatoiy Bowel Disease
Principal Investigator: Michael T. Bach 
Under the direction of D. Balfour Jeffrey, Ph.D.
1. Purpose of the Research Project
The purpose of this study is to examine the relationship o f several factors—health 
beliefs, patient knowledge, and satisfaction with social support—to health-related quality 
of life in patients with inflammatory bowel disease (IBD) Despite the attention given to 
pharmaceutical and surgical treatments o f the physical symptoms of IBD, less research 
has been devoted to studying the other areas that this illness effects, such as emotional 
and social functioning (areas subsumed under the heading, health-related quality of life).
The major hypothesis of this study is that the above factors will predict health-related 
quality o f life better than will disease activity alone. If this prediction occurs, 
interventions based on this finding will be discussed. These include increasing a person’s 
belief in his or her ability to effect positive health outcomes, providing information about 
IBD to interested patients, and providing interested people with listings of local IBD 
support groups.
2. The Subjects
The subjects will be 100-150 persons from Michigan who are 18 or older and who 
have a diagnosis o f inflammatory bowel disease.
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3. Recruiting or Selecting Subjects
Potential subjects will have the study briefly explained to them by a 
gastroenterologist from Michigan during a regularly scheduled appointment. Those who 
wish to participate will be given a packet containing questionnaires measuring the above 
constructs.
4. Where the Study Will Take Place
Subjects will complete the questionnaires at their homes in Michigan. The 
information gathered from the questionnaires will then be analyzed in Montana.
5. The Activities the Subjects Will Perform
The subjects will complete five questionnaires: a Demographic Questionnaire 
(Appendix A) that asks about gender, age, and type o f disease; the Inflammatory Bowel 
Disease Questionnaire (Appendix B), which will measure health-related quality of life; 
the Chapel Hill Index (Appendix C), which will measure disease activity; the 
Multidimensional Health Locus of Control Scale, Form C (Appendix D), which will 
measure a person’s beliefs about how his or her behavior affects health outcomes; the 
Patient Knowledge Questionnaire (Appendix E), which will assess a patient’s knowledge 
about IBD; and the six-item Social Support Questionnaire (Appendix F), which will 
measure a patient’s satisfaction with the social support he or she is receiving. These 
questionnaires are brief, with a total completion time o f  approximately one hour When 
the subject have completed the questionnaires, they will place them in a stamped 
envelope with prepaid postage that is addressed to the principal investigator.
6. Benefits of the Research
If  the predicted results occur, several possible interventions designed to improve the
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health-related quality of life o f IBD patients become promising. These include increasing 
a person’s belief in his or her ability to effect positive health outcomes, providing 
information about IBD to interested patients, and providing interested people with listings 
o f local IBD support groups.
7. Risks and Discomforts to Subjects
The potential risks and discomforts to the subjects in this study are minimal because 
they will fill out the questionnaires only once, and will need only one hour to complete 
them. Although some o f the questions that they will respond to require revealing slightly 
embarrassing information (such as the frequency o f bowel movements in the past two 
weeks), none o f the forms ask for the person’s name. In fact, the Subject Instructions 
(see Appendix H) explicitly state that subjects are not to put their names on any of the 
questionnaires.
8. Minimizing Deleterious Effects
Questionnaire packets will be distributed only to those subjects who express an 
interest in the study. Those who do not wish to participate will not be pressured in any 
way to do so. Once at home, subjects can choose not to complete the forms if they find 
them objectionable for any reason. For such subjects, no negative consequences will 
follow, because the gastroenterologist will not follow-up on their agreement to 
participate.
9. How the Subject’s Privacy is to be Protected
Instead of requiring subjects to write their names, each questionnaire in a packet will 
have an identification number on it. This will eliminate the possibility o f personal 
information being attached to any o f the subjects.
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10. Request for a Waiver of the Written Consent Form
Because o f the sensitive nature of some o f the information gathered, it is essential 
to preserve the anonymity o f the participants in this study. For this reason, a waiver of 
informed consent is requested, as it will ensure total anonymity for the participants. In 
lieu o f a consent form, participants are told in the instructions that mailing back the 
questionnaires is tantamount to giving their consent to participate in this study. In 
addition, every effort has been made to state the voluntary nature of their participation.
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APPENDIX H
PARTICIPANT INSTRUCTIONS
Thank you very much for agreeing to participate in this study. I am interested in 
how certain factors influence health-related quality of life (HRQOL) in persons like both 
you and myself, who suffer from inflammatory bowel disease (IBD) I was diagnosed 
with Crohn's disease about six years ago, and was a patient o f Dr. Noren’s when I lived 
in Marquette. As you know, having IBD affects many areas o f your life in addition to 
physical comfort, like your emotions and your ability to enjoy social activities. These 
areas that are impacted by IBD affect your current satisfaction with life, or HRQOL.
The questionnaires in this packet are designed to measure disease activity (of 
either Crohn’s disease or ulcerative colitis), HRQOL, beliefs about how your behavior 
influences your condition, your knowledge about IBD, and your satisfaction with the 
social support that you are receiving. Hopefully, this study will provide ideas for 
increasing HRQOL in the areas mentioned above. Your participation will help make this 
possible.
Please fill out the questionnaires carefully after reading the instructions on each of 
them, but do not put your name on any o f the forms. By not putting your name on the 
forms you can be assured that the information you record will be kept absolutely 
anonymous. If  you have any questions while completing these measurements, feel free to 
call me at (406) 243-4523. If you find that filling out these questionnaires is 
burdensome, you may dispose of them. I hope, however, that you will complete them, 
because your participation will add to our knowledge about how to improve the treatment 
of IBD. This project should take only about an hour o f your time. Please try to finish 
these as soon as possible and, when you are done, simply seal them up and drop the 
envelope in the mail. Because you will not be signing your name to any of the forms, by 
mailing back the questionnaires you are giving your consent to participate in this study.
If you would like to know more about this research, feel free to call, e-mail, or 
write me at the numbers below; I would be glad to answer any questions. I would also be 
happy to send you a summary o f the results when the study is finished. Thanks so much 
for your time, and I wish you well.
Sincerely,
Michael Bach
Professor D. Balfour Jeffrey, Ph.D.
Study Supervisor
For more information contact:
Michael Bach 
Clinical Psychology Center 
1444 Mansfield Avenue 
Missoula, MT 59812 
e-mail: mbach@.bigskv net 
(406) 243-4523
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APPENDIX I 
IBDQ ITEMS ACCORDING TO SUBSCALE 
Bowel Subscale
How frequent have your bowel movements been during the last two weeks?
How much of your time during the last two weeks have your bowel movements 
been loose?
How often during the last two weeks have you been troubled by cramps in your 
abdomen?
How often during the last two weeks have you been troubled by pain in the 
abdomen?
Overall, in the last two weeks, how much of a problem have you had with passing 
large amounts o f gas?
How much o f the time during the last two weeks have you been troubled by a 
feeling of abdominal bloating?
How much o f the time during the last two weeks have you had a problem with 
rectal bleeding with your bowel movements?
How much o f the time during the last two weeks have you been troubled by a 
feeling of having to go to the bathroom even though your bowels are empty?
How much o f the time during the last two weeks have you been troubled by 
accidental soiling o f your underpants?
How much o f the time during the last two weeks have you been troubled by 
feeling sick to your stomach?
Svstemic Subscale
How often has the feeling o f fatigue or o f being tired and worn out been a 
problem for you during the last two weeks?
How much energy have you had during the last two weeks?
How often during the last two weeks have you felt generally unwell?
How often during the last two weeks have you had problems getting a good 
night’s sleep, or been troubled by waking up during the night?
Overall, in the last two weeks, how much of a problem have you had maintaining, 
or getting to, the weight you would like to be at?
Emotion Subscale
How often during the last two weeks have you felt frustrated, impatient, or 
restless?
How often during the last two weeks did you feel worried about the possibility of 
needing to have surgery because of your bowel problem?
How often during the last two weeks have you been troubled because of fear of 
not finding a washroom?
How often during the last two weeks have you felt depressed or discouraged?
Many patients with bowel problems often have worries and anxieties related to 
their illness. These include worries about getting cancer, worries about never feeling any
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better, and worries about having a relapse. In general, how often during the last two 
weeks have you felt worried or anxious?
How often during the last two weeks have you felt relaxed and free of tension? 
How much of the time during the last two weeks have you felt embarrassed as a 
result o f your bowel problem?
How much o f the time during the last two weeks have you felt tearful or upset? 
How much of the time during the last two weeks have you felt angry as a result of 
your bowel problem?
How much of the time during the last two weeks have you felt irritable?
How often during the last two weeks have you felt lack of understanding from
others?
How satisfied, happy, or pleased have you been with your personal life during the 
last two weeks?
Social Subscale
How often during the last two weeks have you been unable to attend school or 
work because o f your bowel problem?
How often during the last two weeks have you had to delay or cancel a social 
engagement because o f your bowel problem?
How much difficulty have you had, as a result of your bowel problems, doing 
leisure or sports activities you would have liked to have done during the last two weeks?
How often during the last two weeks have you had to avoid attending events 
where there was no washroom close at hand?
To what extent has your bowel problem limited sexual activity during the last two
weeks?
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APPENDIX J
MEANS AND STANDARD DEVIATIONS FOR SCALES IN THE CROHN’S 
DISEASE AND ULCERATIVE COLITIS GROUPS
Instrument
Crohn’s disease* 
Mean SD
Ulcerative colitis** 
Mean SD
c m 211.8 125.8 125.7 127.7
MHLC 20.4 6.7 19.8 7.0
KQ 18.5 6.1 20.3 5.2
SSQ-6 5.1 1.3 5.4 .9
IBDQ Bowel 46.9 11.5 54.5 12.2
IBDQ Systemic 19.7 7.4 24.0 7.2
IBDQ Emotion 52.7 16.9 64.1 12.9
IBDQ Social 25.6 8.1 29.6 7.2
IBDQ Total 144.9 40.3 172.2 36.6
Age 44.6 17.4 48.1 15.5
Length o f illness 14.0 11.6 16.9 14.6
* n = 45; ** n = 17
CHI = Chapel Hill Index (higher scores = more severe symptoms); MHLC = 
Multidimensional Health Locus of Control-Internal; KQ = Knowledge Questionnaire; 
SSQ-6 = Social Support Questionnaire (Satisfaction Scale); IBDQ = Inflammatory Bowel 
Disease Questionnaire (higher scores = improved HRQOL)
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APPENDIX K 
ANNOUNCEMENT OF STUDY IN IBD NEWSLETTER
A  Study of Hecdth^’Related Q^aUty of Life 
in Patients w ith Crohn*s Dweose ;
,  or Ulcerative Colitis -  t
Greetings allt My name is Mike Bach, I am currendy 
working on my Master's thesis at the University of Montena 
with my supervisor, Balfour Jeffrey, Ph.D. I am asking refers to 
consider participating in this study ofhovv œrtain factors are 
related to health-related quality of life in Crohn's disease and ' 
ulcerative colitis. A lot of fantastic research is currendy aimed at 
treating the physical symptoms of inflammatory bowel disease 
(IBD). I am interested, however, in how health beliefs, knowl­
edge about IBD, and satisfaction with social support are related 
to living with this illness. You can help shed light on these 
relationships by tilling out an anonymous questionnaire packet 
that can be completed in less than 45 minutes. If you have IBD, 
are 18 years of age or older, and do not have an ostomy bag, 
please consider e-mailing or sending me an address where you 
can receive the questionnaire packet It will contain instructions 
and a postage-paid return envelope. Remember, your responses 
are TOTALLY ANONYMOUS. Your time can help provide ideas 
to help people who—like both you and myself-^ive each day 
with IBD. I plan to finish this study this fall and will write a 
summary of results from the quesionnaires I receive. The 
Northwest Chapter of the CCFA will publish that summary in 
the Winter 2001 newsletter. Thanks for your help!!!
Mike Bach, O inical Psychology Center 
1444 M ansfield Avenue, Missoula, MT 59812 
e-mail: mbach@ bigsky.net
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